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SUMMARY 
This study was concerned with the measurement of blood pressure 
and the assessment of its patterns and variability in the young 
borderline hypertensive and normotensive male. The effects of 
prolonged ~-adrenergic blockade were also studied in a placebo-
controlled trial of atenolol in 30 borderline hypertensives in 
whom echocardiographic and electrocardiographic parameters were 
examined for possible evidence of early hypertensive cardiac 
hypertrophy. 
Borderline hypertension was defined on the basis of blood pressure 
variation about the arbitrary limits of 140 mmHg systolic and/or 
90 mmHg diastolic during at least three separate office readings 
with random zero sphygmomanometry during a three month baseline 
period. The 15 normotensives in the study at no time exceeded 
these limits during a similar time period. 
Office and home blood pressure levels were significantly greater 
for borderline hypertensives compared to controls. Home blood 
pressure, however, was not significantly different from that 
recorded in the "stressful" hospital environment and this is 
contrary to the findings of previous studies. 
The significant difference in blood pressure between normotensives 
and hypertensives was apparent for the majority of 24 hours when 
continuous ambulatory, intra-arterial records were analysed. Both 
blood pressure categories demonstrated profound night-time falls 
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in blood pressure, with an early morning rise. Day-time 
continuous arterial pressure corresponded closely to indirect 
office and home readings. 
~-adrenergic blockade effectively lowered blood pressure in 
borderline individuals and although a non-significant fall in 
pressure was seen in office recordings in placebo-treated subjects 
this was not demonstrated in 24 hour recordings. The use of atenolol 
was accompanied by minimal side effects and was well tolerated. 
Baroreflex sensitivity was found to be reduced in borderline 
hypertensives, but after chronic ~-adrenergic blockade there was 
a return of sensitivity towards the normotensive range. There 
was no correlation between the degree of blood pressure reduction 
and increase in sensitivity, so it seems unlikely that ~-blockers 
exert their antihypertensive action by a direct effect on the 
carotid baroreceptor mechanism. 
Despite reduced baroreflex sensitivity there was no evidence 
of increased blood pressure variability, measured by the standard 
deviations of the hourly means, from analysis of continuous 
ambulatory blood pressure records of borderline hypertensives. 
In a study of epidemiological data 27% of 913 young males aged 
between 16 and 35 years were found to have a blood pressure 
abnormality and 18% of these fell into the borderline category. 
Thirty per cent of young men of the remaining 9% with mild hyper-
tension satisfied criteria for electrocardiographic left ventricular 
hypertrophy. 
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Despite this observation there was no significant difference in 
electrocardiographic maximum precordial voltage between normo-
tensives and borderline hypertensives in the main area of this 
study. However, after identifying seven borderline hypertensives 
who fulfilled electrocardiographic left ventricular hypertrophy criteria 
it was found that their 24 hour intra-arterial blood pressure was 
significantly elevated throughout most of the day-time period when 
compared to non-hypertrophy individuals. These findings indicate 
a possible relationship between prolonged elevation of left 
ventricular after load and electrocardiographic appearances of 
ventricular hypertrophy. 
Blood pressure reduction had no effect on precordial voltage of 
the electrocardiogram, but at the end of six months there had been 
a significant increase in this measurement in the electrocardiograms 
of placebo-treated individuals. 
Echocardiographic measurement of posterior left ventricular wall 
thickness was found to be anatomically accurate, but no correlation 
was found between electrocardiographic maximum precordial voltage 
and septal and posterior wall thickness. At the same time no 
difference between the echo measurements was seen when normotensive 
and borderline hypertensive values were compared, but blood pressure 
lowering prevented the increase in septal and left ventricular wall 
thickness which was found at the end of six months in the placebo-
treated group. 
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The finding of a significant inverse relationship between 
baroreflex sensitivity and posterior wall and septal thickness 
suggested that early structural changes involving the vasculature 
and myocardium might already be operative and this observation is 
supported by the electrocardiographic and echocardiographic findings 
in this study of borderline hypertension. 
20 
CHAPTER ONE INTRODUCTION AND GENERAL REVIEW 
The benefits of blood pressure lowering in severe or moderate 
degrees of hypertension are now well-established. Following the 
pioneer work of Smirk (1953), which showed an improved prognosis 
in patients with malignant hypertension in congestive cardiac 
failure, treated with the ganglion-blocking agent hexamethonium, 
reports quickly followed on the improved prognosis seen in 
patients in malignant phase treated with blood pressure reduction 
(Morrison, 1953; Rosenheim, 1954; Schroeder, 1955; and McMichael 
and Murphy, 1955). Hodge, McQueen and Smirk (1961) reported an 
improvement in overall mortality in treated, non-malignant, 
hypertension while Hamilton, Thompson and Wisniewski (1964) 
described a significant reduction in stroke occurrence in a 
small series of treated hypertensive males. 
The Veterans Administration Cooperative Study (1967) examined 
the effects of antihypertensive treatment on morbidity and 
mortality in patients with diastolic blood pressures between 
115 mmHg and 129 mmHg. Despite recognised limitations the study 
demonstrated quite conclusively that there was a significant 
reduction in morbidity and mortality when antihypertensive therapy 
was instituted in a male population with diastolic blood pressure 
in excess of 115 mmHg. Little or no data was available, however, 
on the effects of moderately elevated blood pressure until the 
second Veterans Administration Cooperative Study (1970) which 
examined the effects of treatment on morbidity in males with 
diastolic blood pressure in the range 90 nmillg to 114 mmHg. Three 
hundred and eighty men entered the placebo-controlled anti-
hypertensive study and during a five-year treatment period the 
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risk of developing a morbid event was reduced from 55% to 18%. 
Despite the obvious benefits of therapy the results tended to 
support the view that the degree of benefit was related to the 
pre-treatment blood pressure. However, subsequent studies have 
concluded that the achieved, and not the baseline, blood pressure 
is the more important predictor of subsequent morbidity (Beevers, 
Johnston and Devine et ai, 1978 and Trafford, Horn and O'Neal et 
ai, 1981).. The majority of previous pronouncements on the risks 
of elevated blood pressure were based upon only the diastolic 
blood pressure. Reports from the Framingham Study, however, 
suggested that systolic, and not diastolic, blood pressure was a 
better predictor of heart disease in subjects aged 45 years and 
over (Kannel, Gordon and Schwartz, 1971; Kannel, Dawber and 
McGee, 1980) and this was subsequently confirmed by Beevers, 
Davies, Johnston and Larkin (1982). 
There was thus general acceptance that moderate and severe degrees 
of hypertension resulted in increased morbidity and mortality, but 
doubt and disagreement persisted about the effects of milder blood 
pressure elevation. Although the second Veterans' trial (1970) 
had studied patients with diastolic pressures between 90 and 
114 mmHg, it was only in the group with pressure in excess of 
105 mmHg that a clear difference in outcome was detected between 
treated and non-treated subjects. In those with pressures below 
165 mmHg systolic and 105 mmHg diastolic the difference in the 
incidence of morbid events was less well defined. It was felt 
that organic manifestations might have progressed more slowly in 
milder forms of the disease and might therefore not have revealed 
22 
themselves during the relatively short-term period of the study. 
Although no substantial benefit was demonstrated by blood pressure 
lowering in this milder group of hypertensives it has long been 
recognised that each increment of systolic or diastolic pressure, 
even within the "normal" range, is associated with steadily 
increasing risks, but there is no absolute cut-off at which 
mortality suddenly increases (Society of Actuaries, 1959; 
Kannel, Schwartz and McNamara, 1969 and Kannel, Wolf, Verter 
and McNamara, 1970). 
The second Veterans' Study had been criticised on a number of 
points, chief amongst these being that it was a males only study, 
blood pressure classification was based on hospital in-patient 
recordings, there was already a high prevalence of cardiovascular 
complications in the population studied and a substantial number 
of blacks had been included.' These study limitations prompted 
the establishment of a number of .~urther studies in mild 
hypertension. 
The United States Health Service Hospitals Cooperative Study Group 
(McFate Smith, 1977) studied 398 subjects, aged 21-55, with mild 
hypertension for a period of 7-10 years, but with a very high 
drop out rate. Active treatment did not confer any benefit in 
the prevention of myocardial infarction and stroke, although it 
should be emphasised that only 17 such events occurred. However, 
so-called lesser events occurred more frequently in the p~acebo 
group and these included the development of electrocardiographic 
left ventricular hypertrophy. A further point of importance was 
that 12.2% of the placebo group had an increase in arterial 
'" 
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pressure during the period of the study, rendering them no longer 
in the mild hypertensive category. 
The Australian National Blood Pressure Study was begun in 1973. 
This was a controlled therapeutic trial of antihypertensive drug 
treatment in 3,427 men and women with diastolic blood pressures 
between 95 and-l10 mmHg with a systolic blood pressure of less than 
200 mmHg. (The Australian Therapeutic Trial in mild hypertension, 
1980). The study employed rigid exclusion criteria and all 
subjects, of whom almost 50% were less than 50 years, were free 
of prior cardiovascular or cerebrovascular symptoms with a low 
prevalence of smokers. During an average follow up period of 
4 years there was a significant reduction in mortality in the 
actively treated group, mainly due to a reduction in cardiovascular-
related deaths - myocardial infarction, stroke and myocardial 
ischaemia. The number of deaths due to myocardial infarction 
was small - 2 and 8 - in the active and placebo groups 
respectively while the incidence of non-fatal myocardial infarctions 
was almost identical. The number of ischaemic, non-infarction, 
end-points was, however, less in the actively treated group. 
The Australian results were comparable with those seen in the 
Hypertension Detection and Follow-Up Program Study (HDFP) (1979) -
a study of so-called stepped care and referred care for hypertension 
in the United States. Although the American study was somewhat 
unique in that both stepped care and many referred care subjects 
received antihypertensive therapy results in this large group of 
mild hypertensives closely paralleled the Antipodean experience. 
Despite the fact that hypertension is a well-established risk 
factor for the development of coronary artery disease (Tibblin, 
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Wilhelmsen and Werko, 1975 and Gordon and Kannel, 1972) only one 
study (Berglund, Sannerstedt and Anderson, et a1, 1978) had shown 
any benefit in reducing coronary incidents by blood pressure 
lowering prior to the Australian and American HDFP reports. 
The latter findings were, however, not corroborated in Norway by 
Helgeland, (1980). The Oslo Study - a 5-year controlled drug 
trial in 785 mild hypertensive males, aged between 40 and 49 -
found no preventive effect on coronary artery disease, although 
there was a significant reduction in the development of electro-
cardiographic left ventricular hypertrophy. There was, as expected, 
a reduction in stroke frequency in the actively treated group. 
It may not be surprising that considering the small size of this 
study and the relatively short follow-up period that no significant 
difference emerged in cardiovascular morbidity and mortality 
between the treated and non-treated groups. 
During the course of the studies 12% of placebo subjects in 
Australia and 17% of Norwegians exceeded mild hypertensive limits 
and were assigned to active therapy. These figures tended to 
further lessen the overall differences between active and placebo 
groups with mild hypertension. 
It is estimated that there are three million middle-aged Britons 
with diastolic pressures of 90 to 99 mmHg (Editorial, 1980). The 
benefits of treating this large number by drug therapy are still 
not clearly defined and for this reason the British Medical 
Research Council trial has been set up with the somewhat daunting 
task of determining the potential for reducing morbidity and 
mortality from the complications of mild hypertension by 
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antihypertensive therapy (1977). A further question will be: 
Are the benefits of treatment likely to be offset by an increase 
in anxiety, distress and side effects as well as the cost of 
drug-taking? Doubtless, with these points in mind, a number of 
workers have suggested that simple, non-pharmacological factors 
may be effective in lowering blood pressure in mild hypertensives, 
employing sodium restriction (Morgan, 1978 and MacGregor, Markandu 
and Best, et al, 1982) and weight reduction (Reisin, Messerli and 
Dreslinski, et al, 1982), but no long-term studies have been 
conducted in what may be an exciting area of future hypertension 
research. 
So far,.the results of morbidity and mortality in mild hypertension 
have all applied to middle-aged subjects, of whom many already had 
pre-existent end organ damage. It is well recognised that 
hypertension is a slowly, but steadily, progressive disease and 
many authors acknowledge that by the time blood pressure lowering 
is instituted irreversible changes may already be established. 
The study of blood pressure levels, patterns, control mechanisms 
and possible effects on the heart in subjects with mild or 
borderline hypertension, offers the possibility of identifying 
factors that may initiate blood pressure elevation from those 
that sustain it. 
A uniformly accepted definition of borderline hypertension is not 
available, but it could best be described as a condition of 
elevated blood pressure with readings not sufficiently high to 
warrant early treatment (Julius and Esler, 1975). Despite this 
somewhat loose definition it is a condition that has attracted 
wide investigative interest as it appears to be. an early predictor 
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of future established hypertension (Levy, Hillman and Stroud, et 
al, 1944 and Julius and Schork, 1971). There is also evidence that 
the condition carries an excess of overall mortality (Levy et al, 
1944; MacKenzie and Shepherd, 1937; Mathisen, Loken, Brox et 
al, 1965 and Lew, 1967) and an increased frequency of future 
cardiovascular complications '(Thomson, 1950; Stamler, Lindberg, 
Berkson, et aI, 1958; Mathewson, Brereton, Keltie, et aI, 1965 
and Kannel, Schwartz and McNamara, 1969). 
The condition has been bedeviled by poly-terminology - mild, 
borderline, labile and pre-hypertension being among the terms used. 
Pre-hypertension has now been largely dropped as a descriptive 
term as it is now known that many subjects with mild, or 
borderline, hypertension do not go on to develop later, established 
forms of the disease (Julius and Schork, 1971; Doyle, 1982). The 
term labile would, at first glance, appear eminently suitable to 
describe the patient who is at one time within the hypertensive 
range while at another time appearing to be normotensive. Julius, 
Ellis, Pascual, et al, (1974) assessed blood pressure lability in 
young borderline and normotensive students by using the standard 
deviation from the mean of cuff readings recorded at home and in 
an office setting. Borderlines had an increased lability of systolic, 
but not diastolic, arterial pressure. Hm-lever, Pessina, Normino 
Semplicini, et al, (1979) did not confirm this observation, but 
it should be added that their studies were confined to hospital 
in-patients. 
There is thus cause for debate about the suitability of the term 
"labile" and for the remainder of this dissertation the terms mild 
and borderline hypertension will be used and assumed to be 
synonymous. 
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As arterial hypertension develops, many secondary cardiovascular 
changes occur and in the middle-aged patient there may also be the 
problem of coexistent atherosclerosis. Therefore observations of 
the pathophysiology of hypertension in the older subject become' 
more complex in attempting to determine initiating factors of 
the process from those that are secondary consequences of raised 
arterial pressure, even in the mild or borderline range. The study 
of blood pressure in the young, apparently healthy individual 
would therefore appear to be an attractive area for future 
research into mechanisms which might initiate blood pressure 
elevation and those that sustain, and indeed might result from it, 
According to the hypothesis of Brown, Lever, Robertson and 
Schalekamp (1976) it is proposed that essential hypertension results 
from a small rise in arterial pressure during a period of 
autonomic overactivity, producing renal alterations which 
maintain the arterial pressure rise and become the basis for 
future pressure increments. The hypothesis supposes a borderline 
phase in young life with sequential incremental rises in systemic 
arterial pressure as time passes with resulting renal transformation 
maintaining the blood pressure at an elevated level. 
Although many abnormalities have been reported in borderline 
hypertensives which could be explained by such a neurogenic 
mechanism, attempted correlation with catecholamine levels has 
proved somewhat inconsistent with Nestel and Doyle (1968) and 
Kuschke (1961) describing elevated levels while Esler and Nestel 
(1973) failed to confirm these findings. It is probably true , 
however, that a few patients in the borderline phase have raised 
peripheral catecholamines (De Quattro and Cha~ 1972). There are 
several objections, however, to the application of plasma 
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noradrenaline levels as an index of overall sympathetic nervous 
activity in studies of human physiology - not least being that 
the concentration in the plasma is determined in part by the rate 
at which the catecholamine is removed. The measurement of 
noradrenaline spillover rate may provide a better index of 
overall autonomic activity (Esler, 1982). 
As further supportive evidence of increased autonomic activity, 
~-adrenergic activity has been found to be increased in mild, 
borderline hypertension (Frolich, Dustan and Page, 1966), although 
this finding was not subsequently confirmed, by the same group, 
when borderline subjects with normal resting heart rate were 
examined (Frolich, Kozul and Tarazi, et ai, 1970) 
Major interest in the autonomic nervous system in this early stage 
of hypertension has largely been directed at the sympathetic arc 
but in studies using combinations of propranoldand atropine 
Julius, Pascual and London, (1971) and Julius, Esler and Randall, 
(1975) also found evidence of changes in parasympathetic function 
and postulated a central control abnormality. 
One such area of central control of systemic arterial blood pressure 
is the baroreceptor control mechanism. Gribbin, Pickering and 
Sleight, et ai, (1971) found reduced baroreflex sensitivity in 
some borderline hypertensives, as did Takeshita, Tanaka, Kuroiwa, 
et ai, (1975), but this was not confirmed by Julius, et ai, (1975). 
Using the neck suction method to stretch carotid baroreceptors 
Eckberg (1979) found that baroreceptor sensitivity was unchanged 
in young men with a "milder" form of borderline hypertension, 
but was decreased in subjects of the same age with a resting 
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average systolic arterial pressure of greater than 140 mmHg. 
Eckberg postulated that baroreflex responsiveness might predict 
the subsequent development of hypertensive cardiovascular 
disease. The description of excessive blood pressure variability 
in this borderline phase (Birkenhager, Van Es and Houwing, et aI, 
1968) raises the intriguing possibility that these blood pressure 
fluctuations result from relative baroreflex insensitivity which 
may be the starting point of Brown et aI's hypothesis and thus the 
prime mover in the hypertensive process. 
In the early, or borderline, phase of hypertension the cardiac 
output has been found to be elevated with an inappropriately low 
or normal total peripheral resistance (Widimsky, Fejfarova and 
Fejfar, 1957; and Eich, Peters and CUddy, et aI, 1962). It 
should be stressed, however, that this is a heterogenous group, 
with a raised cardiac output being found in only 40-50% of 
individuals. The finding - albeit not universally present - prompts 
the question; do all hypertensive patients start here? This forms 
the basis of the autoregulation theory put forward by Guyton 
and Coleman (1969) who postulate that the primary increase in 
cardiac output later triggers an autoregulatory increase in total 
peripheral resistance which acts to lower cardiac output, so that 
an equilibrium is obtained of normal cardiac output and raised 
total peripheral resistance - the situation existing in established 
hypertension. 
A concept of "structural autoregulation" has, however, been 
advanced by Folkow (1975) and others. This theory, based upon 
vascular hypertrophy secondary to raised arterial pressure, is 
not new as Johnson (1868) described generalised arteriolar 
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thickening in "Bright's Disease ll • It assumes that adaptive 
hypertrophic changes occur in the left heart, conduit arteries 
and precapillary resistance vessels in response to increased 
pressor influences. This then assumes that increased vascular 
resistance can be maintained in the absence of increased humoral 
or vascular smooth muscle activity. It seems likely that this 
structural adaptation occurs early and may be important for not 
only the maintenance but also the initiation of hypertension. 
Recently Yamori, Mori and Nishio, et ai, (1979) have reported the 
finding of cardiac hypertrophy in spontaneously hypertensive rats 
while the animals were still in the pre-hypertensive stage. 
Suggesting that the early detection of left ventricular hypertrophy 
might be a useful indicator of the incipient stage of vascular 
hypertrophy the same workers conducted a survey of Japanese 
schoolchildren aged 6 to 15 years (Saito, Mori and Nishio, et ai, 
1978 and Nishio, Mori and Saito, et ai, 1978). Twenty-two subjects 
were identified as having borderline hypertension and 25% of these 
showed increased echocardiographic left ventricular mass. 
Recently Safar, Lehner and Vincent, et ai, (1979) have described 
a finding of increased ventricular septal thickness in a group of 
young borderline hypertensives. 
The detection of left ventricular hypertrophy has traditionally 
relied upon the electrocardiogram, using a variety of empirical 
criteria to facilitate the diagnosis. Most criteria employ 
arbitrary precordial voltage values and ST-T wave appearances 
which have been based on a comparison between electrocardiographic 
appearances and the weight of the heart at autopsy (McPhie, 1958 
and Romhilt and Estes, 1968) or on clinical findings which might 
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have been expected to result in myoca'rdial hypertrophy (Sokolow 
and Lyon, 1949). 
Despite recognised limitations of sensitivity (Scott, Seiwert and 
Simon, et al, 1952) and both sensitivity and specificity 
(Allenstein and Mori, 1969; and Dolgin, Fisher and Shah, et al, 
1977) the development of electrocardiographic evidence of left 
ventricular hypertrophy remains an important finding in hypertension 
and its appearance in the established hypertensive is an ominous 
harbinger of future cardiovascular complications (Kannel, 1974; 
and George, Breckenridge and Dollery, 1972). Certainly blood pressure 
lowering can result in regression of electrocardiographic left 
ventricular hypertrophy (George, et al, 1972; and Poblete, Kyle and 
Pipberger, et al, 1973), but this is by no means invariable. 
Despite its obvious limitations the electrocardiogram can still 
be, with proper use and interpretation, a simple and widely used 
tool for the detection and follow up of left ventricular hypertrophy. 
There is no data, however, on its value or otherwise in the 
management of the young mild hypertensive, where there is preliminary 
evidence that anatomical left ventricular hypertrophy may already 
be present, even at this presumed early stage of the disease. 
Carter and Estes (1964) found an extremely close relationship 
between electrocardiographic precordial QRS amplitude and heart 
weight, but this only applied when the hearts were above the 
accepted limits of normal weight, suggesting that muscle mass is 
not the only factor to which amplitude is primarily related. This 
finding was corroborated by Sjorgen (1971) who found no significant 
correlation between left ventricular wall thickness measured by 
echocardiography and electrocardiographic voltage criteria. The 
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findings of Brown, Desser and Bechimol (1977) suggested that both 
left ventricular and septal thickness contributed to the appearance 
of increased QRS voltage on the electrocardiogram. 
It should be stressed, however, that none of the studies involving 
left ventricular wall thickness and electrocardiographic appearances 
contained young subjects with borderline hypertension, thereby 
leaving the question of the possible value of electrocardiography 
in this particular area largely unanswered. 
The use of ultrasound in examination of the left ventricle has 
already been mentioned. It should perhaps be remembered that 
although the technique was originally developed for the detection 
and hunting of submarines at the end of World War One its 
adaptation and introduction into clinical cardiology is 
comparatively recent. 
Using commercially available flaw detecting equipment Edler and 
Hertz (1954) obtained information from the living heart by 
applying the crystal of the equipment sound head to the chest wall 
and recording echoes on a single time base. The first cardiological 
diagnosis using the new technique was pericardial effusion by 
Edler (1955) who described the separation of echoes between 
the anterior wall of the heart and the pericardium. Equipment at 
this stage was rudimentary and recognition of cardiac structures 
uncertain, but Wild, Crawford and Reid (1957) described findings 
on the excised human heart, thereby supplying additional 
information on the ultrasonic appearance of the organ. 
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During the fifties Edler and his colleagues continued their studies 
with the new technique and described the ultrasound features of 
mitral stenosis, left atrial tumours, aortic stenosis and 
pericardial effusion (Edler, Gustafson, Karlefors, et al, 1961). 
The technique for pericardial effusion detection provided the 
stimulus for subsequent detailed examination of the left ventricle 
and Feigenbaum, Popp and Chip, et al, (1968) described 
measurements of posterior left ventricular wall thickness, using 
echocardiography, as the technique had now been termed by the 
American Institute of Ultrasound in Medicine. 
The accuracy of the technique was tested by Feigenbaum, et al, 
(1968) by comparing the echocardiographic measurement of posterior 
wall thickness with direct measurement at necropsy and at open 
heart surgery. Despite a good statistical correlation between the 
echo and direct measurement dimensions, methodological limitations 
must cast some doubt on the study's conclusions. The measurement 
at open heart surgery was, to say .the least, crude with a needle 
being inserted into the apex of the left ventricle with the heart 
still beating. It is difficult to reconcile an apical measurement 
being representative of the wall thickness at the postero-basal 
surface where the echo measurement is taken, anq this was indeed 
recognised by the authors. The absence of diastolic/systolic 
~ 
separation while performing measurement in a beating heart also 
renders the results somewhat suspect. A closer correlation was 
reported between the necropsy measurement - where direct 
measurement was actually performed at the postero-basal surface -
and the echocardiographic end-diastolic dimension. This latter 
finding was also reported by Schroeder, Popp and Stinson, et al, 
(1969), but was not confirmed by Maron, Henry and Roberts, et al, 
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(1977) who found no necropsy correlation with the echocardiographic 
end-diastolic dimension, but rather a close comparison with the 
end-systolic dimension. Despite these reported inconsistencies 
there has been a plethora of echocardiographic studies of left 
ventricular function and mass etc. in a variety of cardiovascular 
states. 
The ability to detect left ventricular hypertrophy by echocardio-
graphy in hypertensives before the appearance of electrocardiographic 
changes has been described by Dunn, Chandraratna and de Carvalho, 
et al, (1977). In the absence of coronary artery disease these 
workers also reported a decrease in left ventricular performance 
with increasing arterial pressure and left ventricular hypertrophy -
a finding previously reported by Mehmel, Mazzoni and Krayenbuehl, 
(1975). A later study involving echocardiographic assessment of 
left ventricular function and anatomy in 234 asymptomatic 
hypertensives detected a significant number of cardiac abnormalities 
which were not apparent on the electrocardiogram or chest x-ray 
(Savage, Drayer and Henry, et al, 1979). The ability of the 
technique therefore to detect increases in left ventricular 
wall thickness before the appearance of electrocardiographic 
changes makes echocardiography an appealing investigative tool 
in the study of mild hypertension. Few studies have been 
performed, but Safar, et a1, (1979) have reported increased septal 
thickness in young borderline hypertensives, while the Japanese 
have detected echocardiographic abnormalities in hypertensive 
children (Nishio, et a1, 1978). 
Bearing in mind the importance of early hypertrophy recognition 
against the background of its possible role in the initiative 
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process of hypertension and the subsequent unfavourable prognosis 
that its development carries, it would appear to be extremely 
important that echocardiographic data be compared with accurate 
and prolonged periods of blood pressure measurement. 
36 
CHAPTER TWO AIMS OF THE STUDY 
From the work cited in the introduction it is likely that mild, 
borderline hypertension may be the earliest stage of the 
hypertensive process with all of its attendant complications. 
The aims of this study were the examination of intra-arterial 
continuous blood pressure patterns in young unrestricted men in 
order to assess absolute levels of systolic and diastolic pressure 
and to determine the extent of their pressure variability. The 
so-called "lability" of blood pressure has been linked to a 
possible abnormality of the baroreflex mechanism and it was felt 
that this arc should be studied in normotensives and in mild 
hypertensives before and after chronic ~-blockade. As increased 
p-adrenergic receptor activity has been postulated as a possible 
contributary mechanism in borderline hypertensives the observation 
of effects of ~-blockade on baroreflex sensitivity was of added 
interest. 
No previous study has reported on the long-term useage of 
13-blockers in young, otherwise healthy, mild hypertensives. Do 
they lower blood pressure? Do they have an unacceptable level of 
side effects? These were thought to be important questions to 
answer as evidence accumulates that the treatment of mild 
hypertension in the older age groups confers benefit. 
".~ 
Surprisingly little or no information is available regarding 
electrocardiographic appearances in this area of hypertension 
research. The examination of the electrocardiogram was undertaken 
alone and in conjunction with echocardiography in an attempt to 
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examine the effects of mild blood pressure elevation on left 
ventricular wall thickness. This was coupled with accurate and 
detailed blood pressure profiles, employing office and home 
measurements with, for the first time, 24 hour, continuous, 
ambulatory intra-arterial blood pressure recording. 
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CHAPTER THREE SUBJECTS AND METHODS 
Young, apparently healthy, males aged between 18 and 35 were 
recruited for the purposes of the project. Volunteers were 
obtained primarily from two sources - the Australian Public Service 
and an institute of tertiary education - but also included medical 
staff. No fee or other inducement was offered to volunteers. 
During a three month lead-in period subjects underwent a number 
of preliminary investigations, including a full physical 
examination, chest radiology and routine biochemical screening. 
An initial attempt was made to quantify salt intake, but this was 
eventually abandoned owing to a number of factors. As a result 
of widespread television and press coverage dietary salt had been 
conclusively implicated in the genesis of hypertension in the 
minds of most young Australians. Food manufacturers either 
were unaware of salt content of their products or were loathe to 
supply information. When pre-weighed salt shakers were given to 
individuals in an effort to assess the amount of added salt used, 
few used them because of already referred to indoctrination. 
Blood pressure was recorded on at least three separate occasions 
under rigidly standardised conditions according to recommendations 
of the Australian National Blood Pressure Study (Abernethy, 1974). 
Subjects remained sitting quietly for five minutes before blood 
pressure was measured by a Hawksley Random Zero Sphygmomanometer 
taking phase V Korotkoff as diastolic. After a further three 
minutes the procedure was repeated. The mean of both values was 
recorded as the representative figure. 
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Individuals were deemed to be normotensive if their systemic arterial 
blood pressure at no time exceeded 140 mmHg systolic or 90 mmHg 
diastolic. Those subjects who displayed a "constant" blood pressure 
abnormality - ie a sustained elevation of systolic arterial blood 
pressure > 140 mmHg and/or 90 mmHg diastolic were classified as 
established hypertensives and were further investigated and kept 
under review at a Renal Hypertension Clinic. Those individuals 
who displayed a variation in blood pressure whereby at least one 
reading exceeded the arbitrary limits and at least one below were 
classified as mild or borderline hypertensives. 
On the basis of the above criteria and in the absence of underlying 
pathology, 30 young men were classified as mild hypertensives 
while 15 were found to be normotensive. There was a certain bias 
in favour of hypertensive volunteers as young men who had previously 
been found to have a blood pressure abnormality came forward more 
readily for investigation. 
40 
TABLE 1 
PHYSICAL CHARACTERISTICS OF STUDY SUBJECTS 
Normotensives Mild Hypertensives 
(n=15 ) (n=30) 
Age (years) 26.3 ± 5.10 27.2 ± 4.96 N S 
Height (cm) 181.3 ± 5.2 179.7 ± 6.57 N S 
Weight (Kg) 76.1 ± 7.6 79.78 ± 12.73 P < 0.01 
RESULTS mean ± S D. 
Hypertensives were therefore slightly, but significantly, 
heavier than their normotensive counterparts. The level 
of activity and physical fitness was generally high, but 
did not differ between groups. There were no trained 
athletes in either group. 
These individuals participated in the studies to be described 
except in the study of precordial variation in the normal 
electrocardiogram, (chapter 10) where, for logistical purposes, 
16 young, normotensive hospital workers formed the study 
population, and in the determination of the anatomical accuracy 
of M - mode echocardiography (chapter 12) where study subjects 
were hospital patients undergoing cardiac investigation and 
surgery. 
The methodological procedures employed in the study will be 
described in relevant chapters. 
CHAPTER FOUR 
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THE METHODS FOR MEASUREMENT OF 
SYSTEMIC ARTERIAL BLOOD PRESSURE 
The arterial pressure in man may be measured in two basic ways; 
directly, by inserting a catheter into an artery, or indirectly, 
by applying a pneumatic cuff to the upper arm which initially 
occludes the brachial artery When inflated and, on slow deflation, 
the pulse wave first passes through representing systolic 
pressure and diastolic pressure is represented by its maximum 
amplitude. 
Direct Method 
The final arbiter of the accuracy of systemic arterial pressure 
measured by indirect methods is the pressure measured directly 
in the arterial lumen. This latter technique requires expertise 
and is not without hazard. It demands that relatively wide-bore 
cannulae be inserted into arteries of reasonable size, that the 
connecting tubing be short and that the pressure transducer and 
recording system have high frequency characteristics to ensure 
absolute accuracy. The system should be insensitive to 
temperature changes and easily calibrated. Air bubbles in any 
area will result in damping and inaccuracy and the system should 
therefore be designed in order to ensure that these are easily 
seen and readily removed. 
The direct, intra-arterial, measurement of systemic arterial 
pressure is the final standard of comparison for all measurement 
methods and should be used when comparing blood pressure with 
other physiological parameters and in clinical situations where 
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continuous access to blood pressure ievels is required. The 
recent advent of automatic, portable direct methods of measuring 
blood pressure has exciting implications, but must, at present, 
remain largely a research tool and this is detailed in full 
later. 
Indirect Method 
In 1905 in the Medical Bulletin of the Imperial Military Academy 
of St Petersburg, Dr M S Korotkoff described a method for the 
indirect measurement of blood pressure. He described sounds heard 
over the brachial artery immediately distal to the cuff. The 
Korotkoff sounds are: 
Phase I 
Phase II 
Phase III 
Phase IV 
Phase V 
Sudden appearance of a clear, but often 
faint, tapping sound growing louder. 
The sounds are prolonged into a murmur. 
The sounds become clearer and increase 
in intensity. 
The sounds quickly decrease in intensity. 
Disappearance. 
Korotkoff's description was an advance on the standard method of 
Riva-Rocci (1896), and modified by Von Recklinghausen (1901, 1906, 
1930), who recommended a 13 cm wide and 30 cm long cuff connected 
to a mercury manometer. 
The mercury instrument has through the years become the mainstay 
of blood pressure measurement and life assurance statistics and 
all large epidemiological studies of blood pressure have relied 
on this device. The accuracy of the method when compared to 
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direct measurement has been attested to by early workers 
(Hamilton, Woodbury and Harper, 1936 and Steele, 1942) and 
more recently by Hunyor, Flynn and Cochineas, 1978 who found 
that the indirect method underestimated systolic pressure 
by 10 mmHg and overestimated diastolic pressure (phase V Korotkoff) 
by 8 mmHg. 
Phase V Korotkoff is now generally regarded as representing true 
diastolic pressure and will be used throughout this study. However, 
there are situations of high flow such as pregnancy, fever and 
thyrotoxicosis, where Korotkoff sounds may persist to zero and 
here phase IV is used to represent diastolic blood pressure. 
Great care has to be taken, particularly in severe hypertensives, 
to recognise the possible existence of an auscultatory (silent) 
gap (Ragan and Bordley, 1941). 
A further possible source of error in blood pressure measurement 
by the indirect method is the use of an incorrect size of arm 
cuff. It has been found that the standard 12 cm wide cuff gives 
falsely high values for pressure when applied to fat arms 
(Pickering, Roberts and Soury, 1954 and King, 1967). Kirkendall, 
Burton, Epstein and Freis, 1967, recommended that the length of the 
cuff bladder should be such that it half encircled the arm while 
a cuff width of 12 to 14 cm was adequate for the 30 cm adult 
arm circumference. Geddes and Whistler (1978). in an elegant 
study have reaffirmed that a cuff that is too narrow overestimates 
and a cuff that is too wide underestimates systemic arterial 
pressure. 
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Digit preference and observer bias are further areas of error, 
particularly in epidemiological studies and in hypertension research. 
Largely as a result of this, the London School of Hygiene 
sphygmomanometer (Rose, Holland and Crawley, 1964) and the 
Random Zero Machine have been devised to minimise these 
tendencies. In this study all office blood pressure measurements 
were performed by the Hawksley Random Zero Sphygmomanometer 
(Garrow, 1963 and Wright and Dore, 1970). The instrument consists 
of a conventional 0-300 mmHg sphygmomanometer, but fitted with a 
zero shifting device so that true zero cannot be determined until 
after the blood pressure has been taken. 
CHAPTER FIVE 
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RESULTS OF HOME BLOOD PRESSURE READINGS 
IN NORMOTENSIVE AND BORDERLINE INDIVIDUALS 
"One of the most tantalizing aspects of the study of arterial 
pressure is that the methods used for measurement affect the 
value we seek to measure" (Pickering, 1968). 
Perhaps the simplest, safest and cheapest way of assessing blood 
pressure levels away from the anxiety-producing hospital or surgery 
environment is by instructing the subject in the measurement of 
his own home blood pressure. 
This method of home blood pressure assessment has been used by a 
number of investigators (Wilkinson and Raftery, 1978 and 
Raftery, 1974). Julius et ai, (1974) employed the technique in 
a large study of borderline hypertensives and found that although 
blood pressure was generally lower at home approximately 30% of 
the borderline subjects maintained "hypertensive" levels at home. 
The technique may therefore be useful in identifying subjects who 
may .show substantial deviations from office readings and also in 
compiling a blood pressure "profile", rather than isolated 
readings at a point in time. 
Method 
Subjects were instructed in the use of an aneroid instrument -
the Bosch Home Blood Pressure Sphygmomanometer. This unit is 
comprised of a pneumatic cuff with a built-in stethoscope 
diaphragm which is positioned over the brachial artery of the 
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non-dominant arm. The cuff is then tightened by means of 
adjustable straps; the device is represented diagramatically 
in figure lb. Each subject was instructed in quite intensive 
fashion, to recognise Korotkoff sounds I, IV and V until he was 
in agreement, to within 2 mmHg, with the instructor using an 
interconnected stethoscope (fig la). 
Each individual was provided with a record sheet and instructed 
to record his blood pressure in the morning at least 30 minutes 
after rising and again in the evening before retiring to bed. 
The mean of the 14 readings recorded over seven days was taken 
as the representative home blood pressure. 
TABLE 2 
RESULTS 
Comparison (mean ± SO) of Normotensive and Borderline Hypertensive 
Blood Pressure Levels and Heart Rate 
Borderline 
Normotensive Hypertensive Significance 
Office Readings (mmHg) 
Systolic 119.9 ± 6.30 136.8 ± 9.11 P < 0.001 
Diastolic 70.8 ± 6.44 86.6 ± 6.41 P < 0.001 
Heart Rate (beats/min) 66.5 ± 8.51 76.2 ± 8.50 N S 
Home Readings (mmHg) 
Systolic 122.2 ± 8.14 134.6 ± 8.88 P < 0.001 
Diastolic 76.2 ± 6.03 85.4 ± 8.92 P < 0.001 
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The results in table 2 demonstrate th~t the significant difference 
in both systolic and diastolic blood pressure seen in office 
readings between normotensives and mild hypertensive individuals 
was maintained in the home environment. Conversely, there was no 
significant difference between office and home blood pressure 
values, although the rise in home diastolic blood pressure in 
normotensives just failed to reach statistical significance at 
the 5% level. 
Discussion 
These results, and indeed the absolute values, are in close 
accord with those obtained by Julius et al (1974) in a study of 
large numbers of young males with borderline (labile) hypertension. 
Certainly there are objections to home blood pressure; the subject 
must perform isometric exercise to inflate the cuff, with the 
resultant theoretical objection that this will raise his blood 
pressure. Simultaneous measurement of intra-arterial pressure 
during this manoeuvre shows that this objection is unfounded 
(personal observation) •. Certainly there is no foolproof safeguard 
against observer bias and digit preference, but when dealing with 
highly motivated and intelligent individuals this artefact is 
hopefully lessened. 
Despite these possible limitations, the method is of considerable 
value in corroborating careful, repeated office readings. 
The absence of any difference in heart rate between both groups 
should be stressed, as the commonly held belief that an office 
tachycardia with raised blood pressure being due to anxiety is not 
supported by these findings. 
CHAPTER SIX 
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THE EQUIPMENT AND TECHNIQUE OF CONTINUOUS 
AMBULATORY 24 HOUR INTRA-ARTERIAL BLOOD 
PRESSURE MONITORING 
The first description of automatic recording of directly measured 
arterial blood pressure was by Bevan, Honour and Stott (1966). 
The equipment incorporated a perfusion pump and transducer with 
connection to a galvanometer which recorded optically on to slow 
moving paper. The analysis of the blood pressure record was 
tedious and time-consuming as the paper trace had to be enlarged 
five to six times and then viewed through a calibration grid. 
Resolution of individual arterial waveforms was extremely poor 
because of the very slow paper speed. 
With the advent of micro-electronics miniaturisation was 
incorporated into a system based upon the pioneer device. This 
resulted in incr8ased reliability and greatly improved recording 
characteristics (Littler, Honour, Sleight and Stott, 1972). The 
present instrument basically consists of three units, a perfusion 
pump, transducer and miniature analogue tape recorder - the 
Oxford-Medilog system (Bevan, Honour and Stott, 1969 and 
Goldberg, Raftery and Green, 1976). 
Perfusion/Transducer System 
The transducer is an Akers 831B* series, designed for use where 
small dimensions are required. A silicon beam with a planar 
resistor diffused on each side is the basic element of the 
* 
Akers Electronics 1191 Horton, Norway. 
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of the transducer. The pressure sensitive membrane converts the 
applied pressure into a proportional deflection of the beam. 
This deflection gives a linear change in the two diffused 
resistors. By the application of a DC voltage the guage pressure 
is converted into electrical signals. 
The perfusion system was developed at Northwick Park, Middlesex 
(Millar-Craig, Hawes and Whittington, 1978) where a major 
innovation was the replacement of the former butane gas perfusion 
pressure drive by a perfusion pump driven by a constant speed 
motor, which, in turn, is powered by a co~~ercially available 
camera battery. The flushing fluid is contained in a 35 ml 
reservoir within the reinforced perspex unit. The flushing 
fluid was normal saline with 3,000 iu of heparin in 500 mls 
with a flow rate of 1.5 - 2 ml/hour and at this rate of flow 
replenishment was required every 15 hours. The unit's dimensions 
are shown in figure 2. In operational use the perfusion/ 
transducer unit was held in a pouch which was suspended from the 
neck by a harness with the transducer being held at the level of 
the right atrium (fig 3) . 
Recorder 
The signal from the transducer was recorded on one channel of a 
miniature four-channel analogue tape recorder (Medilog, Oxford 
Medical Systems) which had been modified for voltage stabilisation 
(Kenny, Hunyor and Renwick, 1980) (fig 4). The second channel 
was utilised by the electrocardiogram from electrodes in the Vi 
and V5 position. On the third channel signals from the "event 
marker" were recorded. The miniature tape recorder was contained 
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in a leather pouch and this was worn on a belt. The slow speed 
of the tape recorder allowed a commercially available cassette 
to run for 24 hours without changing sides. 
Arterial Cannulation 
Brachial artery cannulation was performed in the non-dominant 
arm under sterile conditions. A point of maximum pulsation was 
identified on the medial aspect of the upper arm, well clear of 
the ante-cubital fossa. Under local anaesthesia a 3F Grandjean 
teflon cannula was inserted into the artery using a Seldinger 
technique with a flexible guide wire (Ronald Howell Ltd) • 
After scrupulous inspection of the connection system to 
eliminate possible bubbles the cannula was connected to the 
perfusion/transducer unit by means of a clear, narrow bore 
tubing. This was taped to the inner aspect of the arm and 
chest wall incorporating safety loops, to ensure safety and 
comfort. (Fig 5). 
Prior to use the perfusion system was wet-sterilised using 
Cidex on an overnight basis. Before filling with heparinised 
saline the entire system was thoroughly flushed free of the 
sterilising agent. 
Before arterial pressure recording was commenced the transducer 
was calibrated by connecting directly to a mercury manometer and 
recording 50 mmHg increments from 0-300 mmHg, holding each value 
for two minutes. By the use of a centre zero galvanometer and a 
monitoring plug in point on the case of the recorder it was possible 
to check the integrity of input signals to the magnetic tape. (Fig 6) • 
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FIGURE 6 
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Arterial pressure was directed to the transducer by means of a 
three-way safety-lock connector on the superior aspect of the 
perfusion device (fig 2). Subjects were instructed in the use 
of the "event-marker" and supplied with a laminated card which 
contained details of the equipment and emergency telephone 
numbers. All subjects in the study were fully ambulant 
individuals who went about their daily business after the system 
had been calibrated and connected. All studies commenced 
between 0900 and 1000 and subjects returned between 6 and 7 hours 
later for topping up of the perfusion chamber and further 
calibration. 
CHAPTER SEVEN 
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CONTINUOUS AMBULATORY BLOOD PRESSURE AND 
HEART RATE IN UNTREATED BORDERLINE 
HYPERTENSIVE AND NORMOTENSIVE YOUNG MEN 
Blood pressure is a continuous physiological variable. During a 
24 hour period the heart beats approximately 115,000 times with 
the corresponding generation of systolic and diastolic arterial 
pressure pulses; no two beats generate exactly the same pressures 
and beat-to-beat pressure variation appears to be a random process 
influenced by an almost infinite number of variables (Goldberg, 
1977). It is therefore inconceivable that any random measurement 
of blood pressure should be representative of any individual 
patient's "blood pressure". It is, of course, random measurements 
of blood pressure which have formed the basis of blood pressure 
risk studies (Actuarial Society, 1941; Metropolitan Life Insurance 
Co, 1961; Kannel and Dawber, 1974), but the large numbers of 
subjects involved in these studies has gone a long way to make 
their results reliable. 
In a detailed study of the pathophysiology of blood pressure 
isolated cuff measurements would seem to be less than ideal. 
Largely for this reason, 24 hour intra-arterial ambulatory 
monitoring was performed in this study group of young normotensives 
and mild hypertensives. No previous study has examined the 24 hour 
blood pressure patterns of young normotensives, although Millar-Craig, 
Bishop and Raftery (1978) did report on the blood pressure circadian 
rhythm of five young men who although reported as normotensive, had 
originally been referred because of hypertension. 
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Subjects and Methods 
Ambulatory blood pressure was recorded in 30 mild hypertensives 
and 15 normotensive young men, the details of whom have already 
been described. 
All studies were begun at between 0900 ~ 1000 with insertion of 
the intra-arterial cannula and transducer calibration. The young 
men were all outpatients and returned to their everyday activities 
after being fitted with the equipment which was quite unobtrusive 
(fig 7). They were encouraged to engage in normal pursuits and 
this included one individual continuing to ride his motorbike! 
The only limitation imposed by the equipment was the inability 
to shower or take a bath during the 24 hour period. They 
returned to hospital between 1600 and 1800 for calibration and 
topping-up of the fluid reservoir, finally returning the 
following morning for a third and final calibration and removal 
of the device after completion of a 24 hour period. 
Scrupulous attention was paid to the attainment of satisfactory 
haemostasis following removal of the intra-arterial cannula. Firm 
pressure was applied for exactly 20 minutes over the arterial 
puncture site and a tight elastic bandage was then fitted, which 
was worn for 24 hours. All subjects were requested to report 
back immediately should problems arise, but apart from mild local 
superficial bruising no complications were encountered. 
It should be stressed, however, that the procedure is not without 
potential risk. Littler (1976) reported four cases of median 
nerve palsy after cannula removal from the brachial artery. These 
OJ
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complications followed approximately 200 problem-free studies. 
In one patient the catheter had actually come out of its own 
accord with subsequent haematoma formation, while in the 
remainder symptoms followed some hours after study completion. 
The exact cause of the neurological symptoms is unclear, but 
Macon and Futrell (1973) have reported an association between 
haemorrhage and median nerve lesions after cardiac catheterisation. 
It is felt likely that bleeding in the constricted area of the 
ante-cubital fossa results in nerve compression. Certainly in 
Littler's studies arterial puncture was made low towards the 
elbow crease and this may have been a large contributory factor. 
The lack of micro-embolic phenomena reports suggests that the 
heparin/saline perfusion system is efficient in prevention of clot 
formation on the cannula tip. 
No problems were encountered with infection, but on theoretical 
grounds no individuals were studied with a congenital or acquired 
valvular lesion. 
CHAPTER EIGHT 
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RESULTS OF 24 HOUR BLOOD PRESSURE 
AND HEART RATE ANALYSIS IN YOUNG 
BORDERLINE HYPERTENSIVES AND NORMOTENSIVES 
A least squares regression line was computed from the three 
pressure calibration sets and from this an overall calibration 
factor was derived. The taped blood pressure signal was replayed 
at 50 times normal speed on a commercially available Oxford 
Instruments replay unit (fig 8) and this was then fed to a pre-
processor (Hunyor, Larkin and Kenny, 1980) whose accuracy was 
checked with a series of known simulated pressure signals. The 
average blood pressure (systolic, diastolic and mean) and heart 
rate over one minute was taken as the unit of measurement and from 
this 10 minute and 60 minute averages were derived together with 
a "global" 24 hour mean. Beat to beat analysis was only undertaken 
on periods of particular interest. The digitised values for 
pressure and heart rate were stored on disc (computer PDP-ll/03) 
and these values and patterns during 24 hours periods were plotted 
using an XY plotter. Variability of mean systolic and diastolic 
arterial pressure and heart rate was measured as the standard 
deviation (Watson et ai, 1979; and Ogawa, Arai and Takata et ai, 
1981) • 
Periods of pressure damping and artefact were excluded by visual 
scrutiny. Any record having a total period in excess of two hours 
during the 24 hour period of damping or artefact was excluded from 
analysis. 
Satisfactory records were available on 15 normotensives and 
30 borderline hypertensives and these results will be described 
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in this chapter. 
Results 
All values are expressed as mean ± SD and data were analysed by 
Student's t-test for paired and non-paired data. 
TABLE 3 
Mean 24 hour systolic and diastolic arterial pressure (mmHg) and 
heart rate (beats/minute) of normotensives and mild hypertensives 
Mild Hypertensives Normotensives Significance 
(n=30) (n=15) . 
Systolic 127.3 ± 15.33 113.0 ± 8.99 p < 0.01 
Diastolic 71.4 ± 12.05 60.3 ± 10.55 P < 0.01 
Mean* 93.3 ± 12.83 78.6 ± 11.31 P < 0.002 
Heart rate 83.1 ± 11. 56 80.6 ± 9.83 NS 
* Mean ± 1 SD. NS - not significant. 
Results from Table 3 demonstrate the significant difference in 
global 24 hour blood pressure between normotensive and borderline 
subjects. Heart rate, however, was the same for both groups. 
It has been recognised for some time that blood pressure shows a 
bimodal pattern over 24 hours with a marked fall during sleep 
(Millar-Craig et al, 1978) and this is convincingly demonstrated 
in figures 8 and 9. 
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The fall in night-time pressure was highly significant for both 
normotensives and hypertensives and interestingly the degree of 
fall was virtually identical in both groups. The other striking 
feature was the close correspondence between daytime ambulatory 
blood pressure and office and home readings. This was particularly 
the case for systolic pressure. The higher readings for diastolic 
pressure in both office and home readings may be explained, at least 
in part, by cuff overestimation when compared to intra-arterial 
measurement (Hunyor et ai, 1978). (Table 4) • 
24 Hour Blood Pressure and Heart Rate Pattern 
The graphical representation of systolic and diastolic arterial 
pressure and heart rate during a 24 hour period is illustrated in 
figures 8,9 and 10 respectively. At first glance, the most 
striking feature is the quite marked fall in all three parameters 
during night-time hours with a return to daytime levels in the 
early morning. 
Despite the significant difference in values systolic and diastolic 
arterial pressure patterns for both normotensives and borderlines 
show a remarkable constancy with "tracking" throughout the 24 hour 
period. The same is not true for the heart rate, however, where 
there is no sustained difference between the two groups. 
Blood pressure was generally higher in early morning with a fall 
in mid-morning and afternoon and a pronounced peak at about 
1700 hours. This corresponded to the subject returning to hospital 
for re-filling of the perfusion unit and calibration of the trans-
ducer - the effect of the doctor on the patient's blood pressure! 
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There was a progressive fall in pressure throughout the evening 
with a more pronounced drop during sleep and beginning to rise 
again around 0500. 
Systolic and diastolic arterial pressures were significantly 
different between both groups throughout most of the 24 hourly 
intervals (P < 0.05 - 0.001) and in the others differences did not 
quite achieve statistical significance at the 5% level. For 
reasons of clarity and completeness standard deviation bars 
and significance values have been omitted from the figures, but 
are contained in Appendix I. 
Heart rate displayed exactly the same diurnal pattern as blood 
pressure (fig lQ, but whereas there had been a significant 
difference in arterial pressure this was not the case with heart 
rate between both groups. This confirmed observations made during 
office blood pressure measurements (table 2), but is at odds 
with reports that borderline hypertensives maintain a higher resting 
heart rate than normotensive counterparts (Sannerstedt, Julius and 
Conway, 1970; and Julius et al, 1974). 
Blood Pressure Variability 
Variability of systolic and diastolic arterial pressure was measured 
as the standard deviation of the hourly means. 
Systolic arterial pressure variability is demonstrated in fig 11 
and it is clear that there was no difference between groups. For 
the most part diastolic pressure variability obeyed the same rules, 
but there were points in the 24 hours when borderline variability 
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CHAPTER NINE 
73 
THE EFFECTS OF LONG-TERM ?-ADRENOCEPTOR 
BLOCKADE ON BLOOD PRESSURE AND BAROREFLEX 
SENSITIVITY IN YOUNG BORDERLINE HYPERTENSIVES 
Despite the relative "mildness" of blood pressure elevation in 
borderline hypertension it should still be emphasised that levels 
do consistently exceed those found in normotensive individuals, as 
amply demonstrated in the previous chapter. This elevation may be 
consistent with the initial rise in the blood pressure renal 
cascade as postulated by Brown et al (1976) and it might therefore 
be suggested that blood pressure lowering at this presumed early, 
possible autonomic stageof the condition might prevent the onset 
of established hypertension. 
With the prospect of possible life-long therapy any possible 
consequences of long-term drug administration assume great 
importance, particularly in the young, otherwise healthy, 
individual. It has been shown· that ~-adrenoreceptor blocking 
agents are effective in once daily dosage. Gordon (1976) 
demonstrated effective blood pressure lowering in a group of men 
aged 20 - 33 years with essential hypertension. No previous 
study has described long-term therapy with ~-adrenergic blockade 
in the young borderline hypertensive, however. 
It was decided to use the ~-adrenoreceptor blocker atenolol 
(ICI 66.082, Tenormin), 4-(2-hydroxy-3-isopropylaminopropoxy) 
phenylacetamide. The important properties of this compound are 
(a) cardioselectivity; (b) lack of intrinsic sympathomimetic 
properties; (c) lack of membrane-stabilising effect; 
(d) inability to cross the blood-brain barrier (Barrett, 
Carter and Fitzgerald, et al, 1973). It has been shown that the 
74 
drug is an effective antihypertensive in small doses, within a 
narrow range (Hansson, Karlberg and Aberg et aI, 1976; and Jensen, 
Rasmussen and Mosbaek, 1976) and the once-daily administration with 
24 hour control (Floras, Fox and Hassan, et aI, 1979) offered 
obvious advantages. 
It has been suggested that ~-adrenoreceptor antagonists lower 
blood pressure by altering baroreflex activity (Prichard and 
Gillam, 1969). However, subsequent reports have been inconsistent 
and controversial. 
It is generally accepted that baroreflex control of the heart is 
impaired in established essential hypertension (Gribbin, et aI, 1971; 
and Korner, ~7est and Shaw, et aI, 1974), but some doubt exists in 
the borderline group where Julius, Esler and Randall (1975) found no 
abnormality, while Takeshita, et aI, (1975) reported a Significant 
reduction in baroreflex sensitivity. 
It was felt that the reflex control of the heart in response to 
acute elevations of blood pressure should therefore be examined in 
borderline hypertensives and compared with results from normotensive 
subjects. It was also decided to repeat the manoeuvre after six 
months of placebo-controlled atenolol therapy. 
It was hoped that these techniques might also allow comment on the 
question of possible ~-adrenoceptor hyperactivity in borderline 
hypertension. 
The subsequent description will be divided into two sub-sections -
Chapters 9A and 9B, the former containing details of the blood 
pressure lowering effects and the efficacy while 9B will concentrate 
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CHAPTER NINE A RESULTS OF A SIX MONTH PLACEBO-
CONTROLLED TRIAL OF THE B-ADRENORECEPTOR 
BLOCKER ATENOLOL IN BORDERLINE HYPERTENSION 
Thirty young men who fulfilled previously described criteria for mild 
hypertension participated. The design was that of a randomised, 
double-blind, placebo-controlled trial, recognising the problems of 
bradycardia detection in any B-blocker-placebo study. 
Sixteen subjects (Group A) were randomly allocated to the active 
compound, while the remainder (Group B) received placebo. Both 
compounds were identical in appearance and were contained in 
"Calendar-Packs". Both groups were matched for age, height and 
weight. 
TABLE 5 
PHYSICAL CHARACTERISTICS OF SUBJECTS 
ACCORDING TO BOTH TREATMENT REGIMENS 
. Age (years) Height (cm) Weight (Kg) 
Tablet A 26.8 178.9 77.07 
Tablet B 28.1 180.6 82.01 
Significance level Not sig. Not sig. Not sig. 
of difference 
Standard error 1.83 2.43 4.54 
of difference 
Mean baseline systolic and diastolic arterial blood pressure and 
heart rate was not significantly different for both groups and is 
illustrated in table 6. 
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TABLE 6 
Values for baseline blood pressure and heart rate. 
Systolic Diastolic Heart Rate 
(nnnHg) (mmHg) (B/min) 
Tablet A 137.6 87.2 72.4 
Tablet B 135.9 86.0 65.7 
Significance level Not sig. Not sig. Not sig. 
of difference 
Standard error 3.38 2.38 3.29 
of difference 
Subjects in both groups were prescribed half a tablet 
(50 mg atenolol) for the first week of the study, at the end 
of which time the dosage was increased to one full tablet 
(100 mg atenolol) as there were no reports of side effects 
or profound bradycardia. It was decided that one tablet daily 
would be the maximum dose during the period of the study and 
subjects were asked to take their medication at 0800. 
Blood pressure was measured at monthly visits by random zero 
sphygmomanometer and compliance checked by tablet count. The 
period of treatment was six months and at the end of this time 
a side effects questionnaire was administered. 
Prior to randomisation each subject underwent 24 hour continuous, 
ambulatory, intra-arterial monitoring and measurement of baroreflex 
sensitivity. These procedures were repeated upon completion of 
the six month therapy period and details and results are 
described in relevant chapters. During a similar time course 
each volunteer measured his home blood pressure using a Bosch 
78 
home blood pressure sphygmomanometer.' 
TABLE 7 
Baseline home blood pressure levels 
Systolic Diastolic 
(mmH~ (mmHg) 
Tablet A 136.7 86.9 
Tablet B 132.1 83.0 
Significance level Not sig. Not sig. 
of difference 
Standard error 
of difference 3.30 
3.43 
Home blood pressure was recorded for one week, at the same 
time morning and evening, prior to commencing the study and 
during the final week. 
Statistics 
Data on blood pressure and heart rate were analysed by one way 
and two factor analysis of variance. 
Results 
Table 8 shows the mean decrease of systolic and diastolic blood 
pressures and heart rate from the baseline period in subjects 
taking tablets A and B using office recordings. 
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TABLE 8 
Mean decrease of office measured systolic and diastolic arterial 
pressure and heart rate during the six month trial period 
Treatment Systolic BP Diastolic BP Heart Rate 
Tablet A 16.4 13.4 12.7 
Tablet B 6.0 3.8 -5.7 
Significance P < 0.001 P < 0.001 P < 0.001 
of difference 
Standard error 2.45 2.33 2.85 
of difference 
At the end of six months treatment there was a highly significant 
fall in all parameters in the actively treated group. 
Table 9 lists the decrease in systolic and diastolic blood 
pressure recorded at home. The format used was as follows: 
TABLE 9 
Mean decrease of home measured systolic and diastolic arterial 
pressure during the six month trial period 
Treatment Systolic BP Diastolic BP 
Tablet A 10.3 8.1 
Tablet B +1.3 +5.5 
Significance P < 0.001 P < 0.001 
of difference 
Standard error 3.75 3.7 
of difference 
Fig 13 demonstrates the trend for diastolic and systolic blood 
pressure during the six month treatment period, while fig 14 
illustrates the heart rate pattern during the same period. 
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Side Effects 
A side effects questionnaire based upon that used in the Australian 
National Blood Pressure Study (Bauer, Baker, Hunyor and Marshall, 
1978) was administered to each subject upon his completion of the 
six month treatment period. 
Each questionnaire consisted of 22 questions as detailed in 
Appendix II. Due to an oversight, the questionnaire was not 
administered to two subjects, both of whom had taken placebo. 
Physical Activity 
Subjects were asked about limb weakness and symptoms of shortness 
of breath. Only two subjects listed symptoms under this heading -
"Shortness of breath on exertion". Both were taking the active 
compound and both had suffered from childhood asthma. Pulmonary 
function testing was performed before and after oral atenolol, 
but only one subject showed a slight reduction in FEV1 • This 
was not sufficient to cause symptoms and both young men completed 
the trial. 
Sexual Activity 
There were no reports of altered sexual habits or performance, 
although one young man was too embarrassed to answer the relevant 
questions! 
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Skin Rashes 
Skin problems were reported by two subjects - one on placebo. 
The placebo subject had been receiving treatment for an eczema-
like eruption for some time prior to entering the study. A 
pruritic rash in the actively treated subject was situated at 
the anal cleft and was related to obvious haemorrhoids. 
Sleep 
Although nightmares are reportedly a common accompaniment of 
~-blocker therapy only one subject volunteered this side-effect 
and he was taking the active compound. 
Others 
The only other side-effects complained of were dry mouth and 
running nose and these were divided equally between placebo and 
actively treated subjects. 
The Assessment of the Blood Pressure Lowering Effect of Atenolol 
During 24 Hours Using Intra-arterial, Continuous Blood Pressure 
Monitoring 
The details of the intra-arterial, continuous blood pressure 
monitoring technique have already been described in regard to the 
comparison between normotensive and borderline hypertensive 24 hour 
blood pressure patterns. 
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It was felt that the technique would 'also provide interesting 
data on the assessment of antihypertensive therapy in the 
borderline hypertensive, particularly as the hypotensive agent 
used, atenolol, is claimed to lower blood pressure throughout 
24 hours with a single daily dose. 
A total of 30 young men participated in the placebo-controlled 
trial. of atenolol. Ambulatory monitoring of blood pressure was 
performed in all prior to randomisation and a second intra-
arterial study was performed in 23 - 12 on active compound and 
11 on placebo - at the end of the six month trial period. 
Instructions were given to take tablets between 0700 and 0800 on 
the morning of the second study, but to omit medication the 
following morning. 
Results 
The average global 24 hour blood pressure and heart rate data 
for groups A and B before and during antihypertensive therapy 
is illustrated in Table 10. 
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Atenolol substantially reduced systoli"c and diastolic arterial 
pressure and heart rate, while placebo had no effect on any of 
these parameters. However, the presentation of global data masks 
the 24 hour effectiveness of atenolol in lowering systemic arterial 
pressure and this is conclusively demonstrated in figures 15 and 16 • 
The fall in blood pressure was significant (p < 0.05 - 0.001) for 
all hourly periods except during the hours 2300-0600 when the reduc-
tion in pressure did not quite reach the level of significance, 
but at a time when untreated blood pressure was already at its 
lowest level. The 24 hour antihypertensive effect of atenolol is 
demonstrated, however, by the highly significant blunting of the 
early morning rise in both diastolic and systolic pressure. 
The fall in heart rate followed approximately the same pattern as 
blood pressure (fig 17) although the reduction in the morning 
rise in heart rate did not achieve statistical significance -
suggesting that the 24 hour effect of atenolol on heart rate 
reduction is not complete. 
The non-significant fall in systolic and diastolic arterial 
pressure seen in placebo-subjects with office cuff blood pressure 
readings was not apparent in continuous ambulatory blood pressure 
data (figs 18 and 19 ), where the similarity between studies 1 and 2 
was quite remarkable. Indeed, a slight, but significant, rise in 
pressure was evident and this was analagous to the results obtained 
on home blood pressure recording (table 4). 
Comparison of standard deviations of systolic and diastolic arterial pressure 
and heart rate before and during atenolol failed to demonstrate any 
significant difference (appendix I, pages 173-174). 
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92 
ASSESSMENT OF THE BLOOD PRESSURE/HEART 
RATE RESPONSE IN NORMOTENSlVES AND IN 
MILD HYPERTENSIVES BEFORE AND AFTER 
B-BLOCKADE 
It is now generally agreed that baroreflex control of the heart is 
impaired in established arterial hypertension (Gribbin, et al, 1971 
and Korner, west and Shaw, et al, 1974). However, the evidence for 
baroreflex impairment in young, mild hypertensives is not so well 
defined (Takeshita, et al, 1975). The finding of a baroreceptor 
abnormality at this presumed early stage of the hypertensive process 
might be interpreted as indirect evidence that this control 
malfunction may have a role in the initiation of the hypertensive 
process. 
It was therefore decided to compare baroreceptor sensitivity of 
young, mild hypertensive males with their normotensive counterparts. 
Subjects and Methods 
There were 18 hypertensive and 8 normotensive males in this part 
of the study. Criteria-for blood pressure classification have 
already been described. The mean age of the subjects was 
27.2 ± 4.1 years. Studies were performed with subjects lying 
quietly supine in a temperature-controlled room. Intra-arterial 
blood pressure - via the brachial artery - and continuous 
electrocardiograms were recorded on a *Mingograf multi-channel 
recorder at a paper speed of 50 rom/sec. Intravenous bolus 
injections of angiotensin II (Hypertensin elBA), in increments 
of 0.5 ~g to a maximum of 2.5 ~g, were administered via a 
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peripheral venous cannula. 
Baroreflex sensitivity was calculated using the method of Smyth, 
Sleight and Pickering (1969). This involved plotting systolic 
arterial pressure against the succeeding pulse interval during 
the angiotensin-induced rise in systemic arterial pressure to obtain 
a linear plot. Following the return of pressure and heart rate to 
baseline levels the procedure was repeated with incremental 
angiotensin dosage until a rise of 30-50 mmHg systolic arterial 
pressure was achieved. 
Reflex sensitivity was expressed as the slope of the regression 
line (m sec increase in RR interval per mmHg rise in systolic 
arterial pressure). 
Results 
The resting intra-arterial systolic blood pressure of hypertensives 
was greater than the normotensive controls (138.9 ± 17.8 vs 
122 ± 9.5 nunHg i P < 0.001). The average resting heart rate, 
however, was not significantly different (69 ± 9.8 vs 68 ± 9.2 beats/min; 
NS). Baroreflex sensitivity was significantly reduced in the 
hypertensive group when the slopes of both groups were compared. 
(14.6 ± 5.5 m sec/mmHg vs 21.8 ± 7.8 m sec/mmHg i P < 0.001). 
(Fig 20). 
Effects of B-Blockade 
Resetting of the baroreceptor mechanism has been postulated as a 
possible contributory mechanism to the hypotensive action of 
95 
B-blockers (Prichard and Gillam, 1966 and Prichard and Gillam, 1969). 
Hansson (1973) detected an increase in baroreflex sensitivity with 
propranolol,but this was not confirmed by Simon, Kiowski and 
Julius (1977) in a study with another p-blocker, timolol. 
The mild hypertensives participated in a placebo-controlled study 
of atenolol (chapter 9A) and it was therefore decided to re-examine 
their baroreflex sensitivity at the end of a six month treatment 
period. 
Nine hypertensives received atenolol while the remainder received 
placebo. Repeat sensitivity at six months was determined in 
identical manner to that already described. 
Pre-treatment baroreflex sensitivity in the atenolol group 
increased from 16.4 to 25.9 m sec/mmHg (P < 0.001), (fig21 
while remaining unchanged in the placebo group (13.9 to 13.4 m sec/ 
mmHg; N S) (fig 22) at the end of six months. 
There was a significant reduction of systolic arterial pressure 
in the atenolol group (138.0 mmHg vs 118.0 mmHg; P < 0.001), while 
the systolic arterial pressure reduction in the placebo group was 
not statistically significant (133.7 mmHg vs 126.3 mmHg) • 
The effect of acute administration of atenolol on baroreflex 
sensitivity was also determined in four mild hypertensives 
receiving no antihypertensive therapy. Mean age was 22.3 years 
with systolic arterial pressure of 141.3 ± 17.2 mmHg. The method 
for assessing baroreflex sensitivity has already been described. 
A baseline value was obtained after which oral atenolol 100 mg was 
administered. Each subject then remained quietly supine and the 
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procedure was repeated at the end of one hour. 
There was no significant change from baseline blood pressure 
after acute atenolol (141.3 ± 17.2 vs 138.0 ± 11.7 mmHg; N S). 
There was, however, a significant reduction in heart rate 
(72.5 ± 8.9 vs 64.5 ± 6.3 beats/min; P < 0.001). 
The baseline slope was 15.3 ± 10.2 m sec/mmHg and although this 
increased to 19.1 ± 12.2 m sec/mmHg after atenolol this change 
did not reach statistical significance. 
There was no statistical relationship between baseline systolic 
blood pressure and baroreflex slope in any group, nor was the increase 
in baroreflex sensitivity after chronic atenolol therapy related to 
the degree of fall in blood pressure. 
A Comparison of Baroreflex Sensitivity and Variability of Blood 
Pressure in Borderline Hypertensives 
Following baroreceptor denervation Cowley, Liard and Guyton (1973) 
observed that there was considerable arterial pressure variation in 
dogs. This observation added confirmation to the view that the 
baroreflex system is of importance in buffering blood pressure 
variation. Watson, et al, (1979); and Ogawa, et al, (1981) reported 
an inverse relationship between variability of intra-arterial 
pressure measured by standard deviation and baroreflex sensitivity 
in established hypertensives. 
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Borderline hypertensives in this study showed no significant difference 
in systolic blood pressure variability compared to normotensive 
controls. There was, however, an inconstant difference in diastolic 
pressure, but this was never striking. 
Methods 
Baroreflex sensitivity was compared to 24 hour systolic and diastolic 
arterial pressure standard deviation, which was used as the index 
of pressure variability. Data were analysed by linear regression 
analysis. 
Results 
There was no correlation between systolic and diastolic arterial 
blood pressure variability and baroreflex sensitivity in borderline 
hypertensives (r=0.3 and 0.1 respectively; NS). 
Discussion 
These results confirm the view that baroreflex sensitivity is decreased 
in borderline hypertension, while also demonstrating that long-term 
J3-adrenoreceptor blockade exerts a "normalising" effect on the 
baroreceptor mechanism. Acute atenolol administration appeared to 
have no significant effect on sensitivity and this is in agreement 
with other workers (Watson, Stallard and Littler, 1979). The same 
workers also noted that the fall in arterial blood pressure after 
long-term J3-blockade was unrelated to the increase in baroreflex 
sensitivity. 
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There was no relationship between blood pressure variability and 
baroreflex sensitivity. This is, perhaps, not surprising as 
hypertensives did not demonstrate increased variability when 
compared to normotensive controls. 
CHAPTER TEN 
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PRECORDIAL VOLTAGE VARIATION IN THE 
NORMAL ELECTROCARDIOGRAM 
In assessing any therapeutic effect on the electrocardiogram it 
would be valuable to determine the extent of co-existent spontaneous 
variability. Variation of electrocardiographic precordial voltage 
between individuals is well-known, but little information is 
available regarding intra-individual variation in serial 
electrocardiography. Although significant repeat variation has 
previously been described (Simonson, Brozek and Keys, 1949; and 
Michaels and Cadoret, 1967) results may have been largely 
influenced by electrical errors arising from skin-electrode 
resistance variability. Recognition of this problem resulted 
in the recommendation that high impedance input circuits might 
reduce the effect of skin-electrode resistance on amplitude 
variation (Frank, 1956 and Spach, Barr, Havstad and Long, 1966). 
Subsequently, the effective elimination of this source of error 
was demonstrated by the incorporation of buffer amplifiers into 
modern electrocardiograph recorders (Berson and Pipberger, 1968). 
It was decided to study precordial voltage variation in the 
12 lead electrocardiogram of normal male subjects and attempt to 
quantify this in a context which might be useful in determining 
the presence or absence of left ventricular hypertrophy. 
Materials and Methods 
Sixteen normotensive, healthy, male volunteers, aged 18 to 35 
years (mean 24 years) took part in the study. They were randomly 
allocated to one of two groups: A (n=9), B (n=7). 
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Group A: Two 12 lead electrocardiograms were recorded 10 minutes 
apart, following a five minute introductory period, at the same time 
on each of four consecutive days. Chest electrodes were removed 
between same-day recordings. Care was taken to obtain sequential 
electrode position accuracy throughout the study. 
Group B: The procedure here differed from group A only insofar 
as precordial electrodes were not removed in between same-day 
recordings, which were performed at the same time on each of 
three consecutive days. 
Studies were performed at the same temperature-controlled location 
in a relaxed atmosphere with subjects remaining supine throughout. 
All were in a post-absorptive state. 
The same Nihon Kohden* 3 channel direct ~riting recorder, input 
impedance 5 Mohm,was used for each study which was preceded by 
careful calibration with a standard deflection of 1 mm = 0.1 mV. 
Precordial electrode positioning was performed according to 
recommendations of the Americal Heart Association (1954). 
Optimum skin electrode contact was ensured by shaving hirsute 
areas of the chest before silver chloride electrodes of the 
suction type (11 mm diameter and filled with low impedance 
coupling gel) were applied. In group B volunteers,where 
electrodes remained in position during the ten minutes between 
same-day recordings, prominent petechial rings developed after 
the first day, thereby greatly assisting sequential accuracy of 
* Model ECG-4103. Nihon Kohden, Kogyo Co., Ltd., Tokyo, Japan. 
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TABLE 11 
Precordial R + S Amplitude (in 0.1 mv) and 
Heart Rate (Beats/Min) of Group A Subjects on 
Four Consecutive Days 
Subject Heart Rate ECG I 
C.N. 67 38.8 
67 33.3 
59 44 
57 31.9 
P.w. 60 31.2 
55 38.8 
58 33.6 
64 27.4 
J.R. 86 21.7 
77 18.6 
79 24 
75 24.6 
K.H. 54 26 
58 21.7 
52 16.8 
52 16.3 
H.H. 63 28.2 
68 25.6 
71 28.2 
77 27.3 
F.A. 61 28.8 
59 . 35.2 
64 29.8 
58 29.1 
T. S. 57 35.9 
55 39.3 
50 40.1 
52 32.6 
M.P. 60 20.8 
60 26.7 
60 24 
59 27.9 
M.C.P. 58 44.8 
60 45.6 
58 35 
58 44.5 
ECG· II 
37.4 
34.2 
45.3 
40.9 
22.1 
34.5 
37.6 
38 
20.7 
14.4 
26.6 
18.7 
19.4 
19.5 
22.2 
22.3 
28.2 
21.5 
25.5 
24.9 
31.5 
30.1 
27.7 
29.7 
42.2 
36.4 
42.4 
35.6 
20.6 
25.'7 
20.9 
22.5 
37.5 
43 
48.4 
39.9 
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TABLE 12 
Precordial R + S Amplitude (in 0.1 mv) and 
Heart Rate (Beats/Min) of GroupB Subjects on 
Three Consecutive Days 
Subject Heart Rate ECG I 
D.B. 64 44.4 
64 39.3 
64 42.6 
P.K. 56 37 
58 34.2 
57 33.9 
J.K. 58 44.9 
65 42.8 
63 43 
M.R. 53 27.2 
55. 27.25 
55 32.4 
R.S. 71 33.4 
70 33.3 
68 34.4 
A.H. 70 47.7 
70 45.2 
67 44.7 
E.B. 51 45.5 
48 . 44.4 
50 42.7 
ECG II 
43.7 . 
44 
42.5 
36 
34.9 
32.5 
44 
41.6 
43 
27.6 
28.5 
32.3 
33.4 
33.6 
34.2 
46 
44.2 
41.7 
44.5 
44.5 
41.2 
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electrode placement. All 114 traces were of high technical 
quality and none fulfilled criteria for bundle branch block. Traces 
were coded by an assistant to ensure unbiased assessment. 
Measurement of Rand S amplitude was made to the nearest 0.5 mm 
using hand calipers and taking the mean of ten consecutive 
complexes in the precordial leads displaying the larges R and the 
largest S waves. These leads remained consistent for individuals 
throughout the study. 
As the aim of the study was the investigation of precordial 
voltage variation as it might be interpreted in the context of left 
ventricular hypertrophy detectioI1t data ",ere analysed using a model 
based upon McPhie's criteria, which are: 
greatest R + S > 40 mm 
or in the precordial leads 
greatest R + S > 45 mm 
Statistical Method 
Both inter and intra-individual variation was assessed by performing 
an analysis of variance on the additive decomposition of the sum of 
R + S amplitudes (appendix III) . 
Results 
R + S and heart rate data are contained in Tables 11 and 12. 
Group A: The range of variation for same-day and day to day 
recordings was quite large. Intra-individual variation within 
each day was approximately equal to day to day variation, the 
difference being statistically non-significant (Table 13) . 
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TABLE 14 
95% Range of Intraindividual Greatest R + S 
Precordial Voltage Amplitude Variation (in 0.1 mv) 
Group 
A 
B 
Same Day 
6 
2.4 
Day to Day 
7.2 
2.2 
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Group B: Same day and day to day variation was considerably 
reduced when compared to Group A and this reduction was statistically 
significant (P < 0.01). As in Group A intra-individual variation 
within each day was approximately equal to day to day variation. 
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Inter-individual variation in both groups was 60-80% greater than 
intra-individual variation, as might be expected. Comparing 
coefficients of variation for each subject in both groups no 
extreme was seen despite the wide spectrum of R + S values. 
Heart rate was calculated from the mean of the longest and 
shortest R-R intervals in the ten consecutive complexes used for 
amplitude measurement. Mean heart rates were 61.9_± 8.37 and 
60.8 ± 7.28 beats per minute) for Groups A and B respectively. 
Summary 
These results demonstrate the existence of significant precordial 
voltage variation in serial 12 lead electrocardiography, despite 
every effort to minimise known possible causes of variation through 
the application of standardised conditions. Sources of possible 
precordial voltage variation which have been previously described 
include electrode placement, beat to beat variation, tachycardia, 
the post-prandial state, changes in body habitus and fitness and 
drug therapy. 
Benson, et al, 1978, demonstrated that repeat variation was large 
in the orthogonal system with intentional displacement of precordial 
electrodes. In this study of the 12 lead electrocardiogram repeat 
variation was reduced by approximately 60% when precordial 
electrodes were not removed between successive recordings. This 
manoeuvre effectively eliminated variation resulting solely from 
alteration in electrode positioning. 
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Respiration is the most important physiological variable causing 
beat to beat variation (Fischmann, Cosma and Pipberger, 1968; 
and Ishikawa, Batchlor and Pipberger, 1971) and this may be quite 
striking in a clinical setting. The use of 10 consecutive 
complexes for amplitude measurements ensured that respiratory 
variation was substantially lessened. 
Changes in R wave amplitude are known to occur during exercise 
tachycardia (Bonoris, Greenberg, Christison, Castellanet and 
Ellestad, 1977). Brody (1956) suggested that this arose as a 
result of changes in cardiac intracavity blood mass. OVerall, 
Group A subjects demonstrated slightly greater variation in heart 
rate when compared to Group B and this heart rate stability may 
have contributed to reduction in voltage variation, although it 
should be emphasised that no subject in either group was 
tachycardic. 
The study of variation over a short time period eliminated effects 
which might have been encountered in the long term, such as 
changing body habitus or altered fitness status. Certainly a 
positive correlation has been reported between increased ponderal 
index and higher precordial Q R S voltages in normal men (Kilty 
and Lepeschkin, 1965). Increasing physical fitness correlates with 
increased precordial voltage (Van Ganse, Versee, Eylenbosch and 
Vuylsteek, 1970) and echocardiographic studies indicate that this 
may result from increased left ventricular wall thickness (Roeske, 
O'Rourke, Klein, Leopold and Karliner, 1976). 
Although none of the subjects in this study was in a post-prandial 
state, changes in the electrocardiogram have been noted at this time. 
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Ostrander and Weinstein (1964) described changes in the ST 
segments and T-waves during glucose ingestion. 
The choice of young healthy men in this study ensured that none 
was on drug therapy. Digoxin, for example, has been reported 
as causing a sharp rise in Q R S amplitude (Manoach, Grosman, Varon 
and Gitter, 1972), while such unlikely agents as vitamins and 
ferrous sulphate have been shown to have effects on the 
electrical activity of the heart. 
Higher precordial voltages are not uncommon in young men 
(Manning and Smiley, 1964) and in this study four subjects 
intermittently fulfilled McPhie's criteria for left ventricular 
hypertrophy. This latter observation demonstrates that "normal" 
variation may thus interfere with interpretation of serial 
precordial voltage changes in the clinical setting. 
The 95% range of variation in Group A is of importance in the 
assessment of precordial voltage changes in an individual. Failure 
to appreciate this degree of variation may result in the 
misclassification of an electrocardiogram as showing or failing 
to show, left ventricular hypertrophy. The range of variation found 
in this study may be a conservative estimate of that seen in the 
clinical situation, where many of the sources of possible precordial 
voltage variation, minimised in this study, may be operative. 
Although the effects of these other factors might not necessarily 
be additive it does appear likely that their effects would serve 
to compound variation. 
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CHAPTER ELEVEN A THE ELECTROCARDIOGRAM IN HYPERTENSION 
"Electrocardiographic evidence of left ventricular hypertrophy is 
an important result of hypertension; its incidence is directly 
related to the height of the arterial pressure. II Ibrahim, et aI, 
1977 • 
"In the under 35 year age groups there is no relationship between 
systolic pressure and precordial voltage criteria for left 
ventricular hypertrophy, and this suggests that high voltage R waves 
have a different significance in youth." Beaglehole, Tyroler, 
Cassel, Deubner, Bartel and Hames, 1975. 
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THE PREVALENCE OF ELECTROCARDIOGRAPHIC LEFT VENTRICULAR HYPERTROPHY 
IN YOUNG MALES A POPULATION STUDY 
The relatively small numbers of normotensives and mild hypertensives 
in the study rendered it impossible to make any firm pronouncement on 
the prevalence, and therefore the significance, of electrocardiographic 
left ventricular hypertrophy in the young male population. 
Sydney University School of Public Health and Tropical Medicine had 
initiated a study designed to explore occupational factors in 
hypertension and coronary heart disease among the public service 
population under the auspices of Professor D Ferguson (1973). By 
early 1980 4,000 individuals had entered the study and access was 
kindly allowed to computer files to analyse blood pressure and 
electrocardiographic data on males aged between 16 and 35 years. 
Subjects and Methods 
There were 913 individuals in the age range 16 - 35 years with a 
mean age of 25.3 ± 4.2 years. ~lelve lead electrocardiograms were 
performed by trained personnel and classified according to Minnesota 
Code criteria (Blackburn, et al, 1960).. Doubtful tracings were 
referred to an independent cardiologist for adjudication. 
Minnesota code 3,1 and or 3,3 was taken to signify electrocardiographical 
left ventricular hypertrophy. 
Blood pressure was measured according to recommendations of the 
Australian National Blood Pressure Study (ANBPS) (Abernethy, 1974) on 
at least two occasions six weeks apart. On the basis of these blood 
pressure readings subjects were classified into three categories -
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normal, mild hypertension and established hypertension. These 
categories were defined around an arbitrary division of 140 mmHg 
systolic and 90 mmHg diastolic. Those individuals who at no time 
exceeded these limits were classified as normotensive (n=670) while 
established hypertensives (n=83) consistently exceeded either 140 mmHg 
systolic and/or 90 mmHg diastolic. The mild or borderline hypertensive 
group (n=160) comprised those individuals with an intermittent 
variation of arterial pressure about 140 mmHg systolic or 90 mmHg 
diastolic. 
At the initial screening visit each subject's height and weight 
was measured and the Quetelet Index - an indicator of body 
habitus - was derived from the formula 
statistical Analysis 
weight (Kg) 
heighe (cm) x 1,000. 
Data were analysed using X2 analysis and Students' t Test for 
non-paired data. 
Results 
The details of blood pressure (BP) and electrocardiographic (ECG) 
classification are contained in table 15. 
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TABLE 15 
Blood pressure and electrocardiographic classification 
ECG evidence of left ventricular hypertrophy 
BP CATEGORY 
Established hypertension 
Mild hypertension 
Normal 
PRESENT 
25 (30.1)* 
24 (15.0) 
74 (11.04) 
* Percentages in parenthesis. 
ABSENT 
58 
136 
596 
TOTAL 
83 (9.1) 
160 (17.5) 
670 (73.4) 
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Table 16 contains levels for the three blood pressure categories subdivided 
according to ECG status. The difference in blood pressure between left 
ventricular hypertrophy and non-hypertrophy subjects, within blood 
pressure categories, was not significant (NS). 
Within the arbitrarily defined limits of 140 rnrnHg systolic and 90 rnrnHg 
diastolic arterial pressure 26.6% of individuals (n=913) had a blood 
pressure "abnormality" - 9.1% with established hypertension while 
17.5% fell into the borderline category. 
A total of 123 individuals (13.5%) fulfilled the Minnesota Code 
criteria for electrocardiographic left ventricular hypertrophy. Almost 
1 in 3 of those with established hypertension had evidence of 
electrocardiographic left ventricular hypertrophy and this increased 
incidence was statistically significant when compared to borderline 
and normal individuals (p < 0.01). The prevalence rate of left 
ventricular hypertrophy in borderline hypertension and normotensive 
groups was not significantly different. 
TABLE 17 
Values for Quetelet Index by ECG and blood pressure status 
ENTIRE GROUP 
NON-L V H 
L V H 
SIGNIFICANCE (p) 
NT 
23.0 ± 2.9 
23.1 ± 3.0 
22.6 ± 2.6 
NS 
BHT 
24.7 ± 3.2 
24.9 ± 3.3 
23.2 ± 2.6 
< 0.01 
EHT 
24.9 ± 3.4 
25.3 ± 3.3 
24.4 ± 3.1 
NS 
SIGNIFICANCE 
P < 0.01 
p < 0.01 
P < 0.01 
Quetelet index was greater in hypertensive individuals than in their 
normotensive counterparts (p < 0.01). There was no significant difference 
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in quetelet index between borderline and established hypertensive 
groups; however, the presence or absence of electrocardiographic 
left ventricular hypertrophy determined the relationship between 
normotensive and borderline individuals. Those borderline subjects 
without ECG evidence of LVH had a higher quetelet index (p < 0.01), 
but this was not evident in the ECG hypertrophy group (NS). There 
was no significant difference in quetelet index between ECG 
hypertrophy and non-hypertrophy individuals, except in the 
borderline hypertensive group. 
CHAPTER ELEVEN B 
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ELECTROCARDIOGRAPHIC PRECORDIAL 
VOLTAGE IN MILD HYPERTENSION 
The previous chapter described a significant increase in the 
occurrence of left ventricular hypertrophy ECG criteria in those 
individuals with a mild blood pressure "abnormality". 
It was therefore decided to compare electrocardiographic precordial 
voltages of mild hypertensive subjects (n=30) with those of their 
normotensive controls (n=15). It was also decided to examinethe 
effects, if any, of blood pressure lowering by B-adrenoreceptor 
blockade on precordial voltage upon completion of the six month 
treatment period. 
Methods 
Twelve lead electrocardiograms were recorded on all individuals and 
repeated at the end of six months in hypertensives. The same 
equipment was used throughout - a Nihon Kohden, model ECG-4103, 
direct writing, heated stylus, three channel recorder with a pen 
system frequency response of 100Hz (-3db). Recordings were 
performed in a temperature, noise-controlled environment under 
relaxed conditions. Careful skin preparation was undertaken 
to ensure excellent electrode contact and this involved 
shaving of hirsute areas, light abrasion of the skin with 
fine sandpaper and finally cleansing with alcohol. Precordial 
electrodes were of silver chloride suction type (11 rom 
diameter and filled with low impedance coupling gel) and were 
positioned according to the recommendations of the American Heart 
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Association (1954). Absolute accuracy of" precordial electrode 
positioning in sequential studies after a six month period was of 
course difficult, but this was overcome in some degree with all 
electrode positioning being performed by myself. 
Measurement of the precordial Rand S waves was performed in the leads 
showing maximum deflections. Measurements were made by hand 
calipers and the mean of 10 consecutive complexes taken in an 
effort to eliminate respiratory variation. The R + S values were 
summed and are presented in mm. 
All electrocardiographic recordings were of high technical 
quality. 
Data were analysed by Student's It' Test for paired and non-paired 
data and analysis of variance.' 
Results 
The mean value for the sum of the greates R plus the greatest S in the 
precordial leads of the normotensives was 37.04 ± 11.25 mm and this was 
not significantly different from that found in hypertensives 
(38.99 ± 9.85 mm; NS). After six months of atenolol therapy there was 
a significant reduction in the precordial voltage of those individuals 
treated with the active compound (37.64 ± 10.57 vs 33.12 ± 8.33 mm; 
P < 0.01), while no change occurred in the placebo group 
(39.69 ± 9.39 vs 40.97 mm; NS). The difference in precordial voltage 
between the two groups at the end of six months was highly significant 
(33.12 ± 8.33 vs 40.97 ± 8.02; P < 0.02). Body habitus appeared to 
play some role in the appearance of left ventricular hypertrophy in 
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borderline hypertensive individuals as judged from the population 
study data previously cited. There was no apparent association, 
however, in the other groups. Only 7 hypertensive individuals 
fulfilled voltage criteria for left ventricular hypertrophy (McPhie, 1958) 
in this section of the study. There was no significant difference 
between quetelet index of the hypertrophy and non-hypertrophy groups 
(24.4 ± 3.6 vs 24.1 ± 2.7; NS). 
In the population study previously described, there was no significant 
difference in office blood pressure levels between electrocardiographic 
hypertrophy and non-hypertrophy groups. This also applied in this area 
of the study where the blood pressure difference between hypertrophy 
and non-hypertrophy groups just failed to reach statistical significance 
(Table 18) . 
TABLE 18 
Systolic and diastolic arterial pressure levels according to 
electrocardiographic left ventricular hypertrophy criteria 
Arterial Pressure (mmHg) 
Systolic 
Diastolic 
± 1 SD 
ECG-LVH 
142.3 ± 7.87 
88.4 ± 5.50 
NON-LVH 
135.6 ± 8.90 
85.9 ± 6.59 
SIGNIFICANCE 
NS 
NS 
The difference between groups, however. was quite striking, and 
highly significant, when the 24 hour intra-arterial blood pressure 
recordings were examined (Table 19). 
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TABLE 19 
24 hour ambulatory intra-arterial systolic and diastolic arterial 
pressure according to electrocardiographic left ventricular hypertrophy 
criteria 
Arterial Pressure (mmHg) 
Systolic 
Diastolic 
ECG-LVH 
138.6 ± 13.4 
79.8 ± 7.2 
NON-LVH SIGNIFICANCE 
122.7 ± 11.50 P < 0.01 
68.1 ± 6.24 P < 0.01 
The significant difference in arterial pressure between the groups applied 
almost exclusively to the waking hours as demonstrated in figures 23 and 24 
where levels of statistical significance ranged from P < 0.05 - 0.001. 
There was no excessive variability of blood pressure, assessed by 
standard deviation, in either group {Appendix I, page 169). 
ST-T Wave Abnormalities in Mild Hypertension 
Little information is available on electrocardiographic changes, apart 
from precordial voltage, in young borderline hypertensive individuals. 
However, Guazzi, Fiorentini, Polese, Magrini and Olivari (1975) have 
reported T wave changes in their so-called "hyperkinetic heart syndrome" 
in which they postulate that the heart is under excess adrenergic drive. 
Frolich, Tarazi and Dustan (1969) postulated that this was a result of 
increased reactivity of ~-receptors. 
Methods 
ST-T wave segments were carefully examined. Apart from some non-specific 
T wave flattening in lead AVL none of the normotensive individuals 
displayed any abnormality. However, 10 of the 30 borderline subjects 
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displayed t wave inversion in lead III, with one also having 
incomplete right bundle branch block and another t wave inversion 
in lead AVL. These changes were not altered by respiration and 
persisted despite long-term B-blockade. 
Mean arterial pressure was significantly greater in the group with 
T wave abnormalities (107.1 ± 5.78 mmHg) when compared to the 
remainder (101.8 ± 5.71 mmHg; P < 0.02). There was no apparent 
association, however, with precordial voltage. 
Orthogonal Electrocardiography in the Detection of Left Ventricular 
Hypertrophy in Borderline Hypertension 
Of the various non-invasive techniques available to the clinician, 
the vectorcardiogram is among the least used. Since Frank (1956) 
described his practical, seven-lead system for the determination 
of orthogonal vectors the technique's accuracy in the diagnosis of 
left ventricular hypertrophy has been found to be greater (Mazzoleni, 
Wolff and Wolff, 1959 and McCaughan, Littman and Pipberger, 1973), 
the same (Dower and Horn; 1967 and Romhilt, Greenfield and Estes, 1968) 
and less than the 12-lead electrocardiogram (Borun, Chapman and 
Massey, 1966). 
Bahler, et ai, (1977) in a study of apparently normal young subjects 
found a close correlation with septal thickness and the absolute 
value of the Frank lead QRS vector (Vf), a scalar function 
represented by .J X2 + y2 + Z2. 
It was therefore decided to perform vectorcardiography in the study 
in order to determine its usefulness or otherwise in the detection 
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of possible left ventricular hypertrophy and to compare these 
findings with 12-lead electrocardiographic and echocardiographic 
data. 
Subjects and Methods 
Frank lead electrocardiograms were performed on all individuals 
immediately after the recording of the 12-lead electrocardiogram by 
applying the monitoring electrodes in the positions shown (fig 25 ) • 
The instantaneous values of the X, Y and Z components of the Frank 
lead vector system were generated by the appropriate channel on the 
same Nihon-Kohden, ECG-4103 used throughout the study. 
The maximum Frank lead QRS vector (Vf) was calculated and data were 
analysed by t-test for paired and non-paired data and linear 
regression analysis. 
Results 
The value for Vf in the mild hypertensive group was significantly 
greater than the value for normotensives (1.3 ± 0.4 mv vs 0.18 ± 0.02 
mv; P < 0.02). There was a highly significant correlation between 
Vf and the maximum R + S in the precordial ,leads of the conventional 
electrocardiogram but this relationship was only found in the 
hypertensive group (fig26). 
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ANATOMICAL ACCURACY OF ECHOCARDIOGRAPHICALLY 
DETERMINED LEFT VENTRICULAR WALL THICKNESS 
Although a good statistical relationship has been reported between 
posterior left ventricular wall thickness measured by M-mode echocardio-
graphy and direct measurement on the heart during surgery, methodological 
limitations of the study have cast doubt on its conclusions (Feigenbaum, 
et al, 1968). Correlative studies between echocardiography and direct 
measurement at necropsy have been contradictory in their findings. 
Earlier studies reported a close correlation between direct 
measurement and the measurement of posterior wall thicknes in 
end-diastole on echocardiography (Feigenbaum, et al, 1968 and 
Schroeder, et al, 1969). However, Maron, et al, 1977 found that 
the systolic measurement of wall thickness on echocardiography related 
closely to that measured at autopsy. 
In view of these discrepancies it was decided to re-examine the 
relationship between posterior left ventricular wall thickness as 
determined by M-mode echocardiography, in both diastole and systole, 
and direct measurement of wall thickness performed at open heart 
surgery and autopsy. 
Materials and Methods 
High quality echocardiograms were available on 21 patients undergoing 
open heart surgery for a variety of cardiac conditions (table 20). 
Patients were randomly selected from the operating list of one 
surgeon. Prior to the echocardiographic study the purpose and nature 
of the study was explained to patients who gave their informed consent. 
TA
BL
E 
20
 
C
om
pa
ri
so
n 
o
f 
E
ch
oc
ar
di
og
ra
ph
ic
 L
ef
t 
V
en
tr
ic
ul
ar
 W
al
l 
T
hi
ck
ne
ss
 w
it
h 
D
ir
ec
t 
S
ur
gi
ca
l 
M
ea
su
re
m
en
t 
PL
VW
T 
DI
M
EN
SI
ON
 
(m
m)
 
SU
BJ
EC
T 
SE
X 
AG
E 
OP
ER
AT
IO
N 
EC
HO
d 
SU
RG
IC
AL
 
(Y
EA
RS
) 
1 
F 
56
 
CA
BG
 
7.
1 
7.
5 
2 
M
 
61
 
CA
BG
 
10
.4
 
11
.5
 
3 
M
 
74
 
AV
R 
12
.2
 
13
 .5
 
4 
F 
36
 
CA
BG
 
7.
7 
7.
8 
6 
M
 
49
 
CA
BG
 
11
 
11
 
7 
M
 
52
 
CA
BG
 
13
 
12
.5
 
.
.
.
.
.
 
8 
M
 
52
 
CA
BG
 
11
.8
 
7 
w
 
0 
10
 
M
 
47
 
CA
BG
 
11
.5
 
14
.5
 
11
 
M
 
41
 
AV
R 
10
 
11
 
12
 
M
 
57
 
CA
BG
 
7.
9 
7 
13
 
M
 
67
 
CA
BG
 
9 
9 
14
 
M
 
48
 
CA
BG
 
10
 
10
 
15
 
M
 
62
 
CA
BG
 
9 
11
 
16
 
M
 
54
 
CA
BG
 
9.
2 
8.
6 
17
 
M
 
47
 
AV
R 
10
.8
 
10
 
18
 
M
 
51
 
CA
BG
 
6.
4 
7 
19
 
M
 
51
 
CA
BG
 
7.
5 
7.
5 
20
 
M
 
50
 
CA
BG
 
8.
2 
9 
21
 
M
 
41
 
AV
R/
M
VR
 
13
.9
 
13
 
*
5 
F 
RE
PA
IR
 A
SD
 
*
9 
M
 
RE
PA
IR
 A
SD
 
M
EA
N 
±
 
52
.4
 
±
 
9.
8 
9.
9 
S.
D
. 
9.
16
 
2.
09
 
±
 
2.
37
 
*
 
N
ot
 i
nc
lu
de
d 
in
 s
ta
ti
st
ic
a
l 
a
n
a
ly
si
s 
A
bb
re
vi
at
io
ns
: 
CA
BG
 =
 C
OR
ON
AR
Y 
AR
TE
RY
 B
YP
AS
S 
GR
AF
T;
 
AV
R 
=
 A
OR
TI
C 
VA
LV
E 
RE
PL
AC
EM
EN
T;
 
AS
D 
=
 
AT
RI
AL
 S
EP
TA
L 
D
EF
EC
T;
 
MV
R 
=
 M
IT
RA
L 
VA
LV
E 
RE
PL
AC
EM
EN
T.
 
TA
BL
E 
21
 
C
or
;J
po
.r
is
on
 o
f 
E
ch
o
co
.r
di
og
ra
ph
ic
 L
e
ft
 V
e
n
tr
ic
u
la
r 
W
al
l 
T
h
ic
k
n
es
s 
(L
VW
T)
 
w
it
h
 D
ir
e
c
t 
P
o
st
 M
or
te
m
 M
ea
su
re
m
en
t 
AG
E 
(Y
EA
RS
) 
46
 
48
 
55
 
67
 
71
 
57
.4
 
±
 
1
1
.2
 
A
b
b
re
v
ia
ti
o
n
s:
 
D
IA
G
N
O
SI
S 
AS
 
(P
OS
T 
AV
R)
 
PO
ST
 C
AB
G 
M
I 
M
VD
 
IH
D
 
EC
HO
d 
21
 9 10
 8
.8
 
8
.2
 
1
1
.4
 
±
 
5.
41
 
PL
VW
T 
(ro
m)
 
EC
H
O
s 
26
 
1
6.
6 
17
 
1
3.
8 
13
 
1
7
.3
 
±
 
5.
17
 
AS
 
=
 A
O
RT
IC
 S
TE
N
O
SI
S;
 
AV
R 
=
 A
O
RT
IC
 V
AL
VE
 R
EP
LA
CE
M
EN
T;
 
CA
BG
 
=
 C
OR
ON
AR
Y 
AR
TE
RY
 
BY
PA
SS
 G
RA
FT
; 
M
I 
=
 M
YO
CA
RD
IA
L 
IN
FA
R
CT
IO
N
; 
M
VD
 
=
 M
IT
RA
L 
VA
LV
E 
D
IS
EA
SE
; 
IH
D
 
=
 
IS
CH
A
EM
IC
 H
EA
RT
 D
IS
EA
SE
. 
AU
TO
PS
Y 
26
 
17
 
18
 
1
4
.5
 
1
3.
5 
1
7
.8
 
±
 
4.
93
 
.
.
.
.
.
 
LV
 
.
.
.
.
.
 
t"
 
t;:r
:j 
I-I
j 8 <:
 
t;:r
:j Z 8 :;cJ
 
H
 0 c:::
 
t"
 
:J::'
 
:;c
J 
t;:r
:j 0 ::r::
 
0 G"l
 ~ :5: 
N
 
-
.
.
J 
.
.
.
.
.
.
.
 
w
 
N
 
133 
The autopsy group comprised five other cardiac patients (table 21) 
who had undergone echocardiography within one month of their 
death. 
Echocardiography 
Echocardiography was performed using an Ekoline 20 echocardiograph*, 
and a Unirad 2.25 MHz transducer interfaced with an Ekoline strip 
chart recorder operating at 100 mm/sec. Echograms of the left 
ventricle were obtained in a standard manner with the patient 
semi-recumbent in the left lateral position, by positioning the 
transducer at the left sternal edge in the third or fourth inter-
costal space and directing it in an inferior and slightly lateral 
direction so that the ultrasound pathway transversed the left 
ventricular cavity at a level corresponding to the tips of the 
mitral valve leaflets (Feigenbaum, 1976). The diastolic measurement 
of posterior wall thickness, using leading edge methodology, (Sahn, 
De Maria and Kisslo, et al, 1978) was made at the point immediately 
prior to the atrial contribution to ventricular filling -
calculating the mean value over four consecutive cardiac cycles. 
The systolic dimension was measured at the peak of posterior wall 
motion using the same criteria. Measurements were only performed 
on high quality echograms which permitted unambiguous assessment of 
wall thickness. (Figure 27). 
Echocardiography was performed one to two days before surgery, while 
studies had been carried out within one month of death in the autopsy 
group. 
* Smi-th 1\.1 ine Instruments, Inc. Sunnyvale, California 94086. 
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Surgery 
Direct measurement of posterior left ventricular wall thickness was 
performed by the same surgeon upon hearts in asystole under the 
influence of hypothermic cardioplegia - a state corresponding to 
physiological diastole (Melrose, Dreyer, Bentall and Baker, 1955 
and Hearse, Stewart and Braimbridge, 1975) with patients on cardio-
pulmonary bypass. The heart was lifted and rotated medially in its 
long axis so that the area of the left ventricle just below the 
inferior border of the left atrium ... laS visualised. A specialised 
measurement probe (fig 28) was then directed in a direction 
perpendicular to the epicardial surface. The sliding collar was 
advanced to rest lightly upon the epicardium and the adjusting 
screw tightened. The measurement of the gap between the lower 
surface of the collar and the upper aspect of the bulb by calipers 
was taken as the measurement of posterior left ventricular wall 
thickness. 
The surgeon was unable to obtain optimal anatomic positioning for 
direct measurement in the hearts of subjects 5 and 9, who were both 
undergoing repair of atrial septal defect. An additional complication 
was the resumption of contractility during measurement, perhaps as a 
result of sub-optimum hypothermia. Despite achieving good anatomical 
positioning in the heart of subject 8, the exact point of endocardial 
contact could not be confidently felt. All other measurements were 
deemed satisfactory by the surgeon, who was unaware of echocardiographic 
dimensions. No complications resulted from the use of the measurement 
probe. 
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The probe was devised after a series of-trials in the post 
mortem room using a modified venepuncture needle - initially 
with a rubber band wound around the tip and finally with a 
dot of solder. The latter modification allowed the needle to 
impinge on the endocardial surface of the left ventricle during 
slow withdrawal and appeared to cause no significant damage when 
fully withdrawn. 
Specifications as shown in figure 28 were given to the New 
South Wales Institute of Technology who manufactured two probes 
from stainless steel. Between procedures probes were thoroughly 
washed in Cidex and then gas sterilised. 
Post Mortem 
Following removal of the heart at autopsy direct measurement of 
posterior left ventricular wall thickness was performed using the 
probe in similar fashion to that described at surgery. The average 
period from time of death to direct measurement at autopsy was 
16 hours (range 10-22 hours). 
Direct measurement of posterior wall thickness was also carried out 
at 19 consecutive, routine autopsies, in patients where no 
echocardiography had been performed, by two independent observers. 
This manoeuvre served as a modified test of reproducibility for 
the direct measurement technique. 
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Statistical Analysis 
Data were analysed by Student's t Test, with appropriate degrees of 
freedom, and least mean squares linear regression. 
Data on patients 5 and 9 in the surgical group were not included 
in the final statistical analysis as diastolic/systolic separation 
was not possible during operative measurement. 
Results 
The comparative data are represented in figures 29 and 30. 
In the surgical group wall thickness ranged from 7-14.5 rom 
(9.9 ± 2.37 mm) upon direct measurement, while the end-diastolic 
echocardiographic range was 7.1 - 13.9 rom (B.9 ± 2.09 mm). The 
maximum difference between techniques was 4.B rom, in subject B 
(table 20), where direct measurement difficulty was encountered. 
The results therefore show a close correlation (r=0.76; P < 0.001) • 
Neither measurement technique consistently under or overestimated 
when compared to the other. 
Post mortem left ventricular wall thickness ranged from 13.5 - 26 rom 
(17.B ± 4.93 mm). This wide range perhaps reflects the diverse 
cardiac pathology present (table 21). The echocardiographic 
end diastolic range was B.2 - 21 rom (11.4 ± 5.41 rom) and this was 
significantly less than autopsy figures (p < 0.001) (fig 30). There 
was no significant difference, however, between the systolic 
dimension range of values (13 - 26 rom; 17.3 ± 5.17) and those 
obtained at autopsy. 
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The values of posterior wall thickness obtained by two 
independent observers at routine autopsies displayed very 
close correlation (r=0.94; P < 0.001) (fig 3~). 
Discussion 
It has been suggested that left ventricular mass may be a more 
reliable and useful predictor of anatomical left ventricular 
hypertrophy (Devereux and Reichek, 1977). The derivation of mass 
by echocardiographic criteria, however, requires a number of 
important assumptions, chief among these being that the left 
ventricular cavity is truly elipsoid. Cardiac hypertrophy, however, 
is often associated with ventricular dilatation or asynergy, 
particularly in the mature hypertensive, and in these conditions 
extrapolation of one-dimensional data has been found to be inaccurate 
(Teichholz, Kreulen, Herman and Gorlin, 1976 and Bhatt, Isabel-Jones, 
Villoria, Nakazawa, Yabek, Marks and Jarmakani, 1978). 
The measurement of posterior left ventricular wall thickness 
requires no assumptions or extrapolation and results presented 
here confirm the anatomical accuracy of the technique. 
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Measurement of Posterior Left Ventricular Wall Thickness in Dogs 
by M-mode Echocardiography 
Despite evidence presented attesting to the anatomical accuracy of the 
echocardiographic measurement of left ventricular wall thickness no 
previous study had attempted to examine the sensitivity of M-mode 
echocardiography in determining serial changes of left ventricular 
wall thickness in response to increasing blood pressure. 
A dog model had a number of attractions in this area: 
1 The small anteroposterior diameter of the dog chest allowed 
for the use of a higher frequency transducer - 5 MHz - with 
a corresponding increase in resolution of echo recordings. 
2 The use of the dog allowed the placing of an epicardial 
marker, prior to the commencement of studies, ensuring that 
the same area of the posterior left ventricular wall was 
measured by echocardiography and direct measurement when the 
animal was sacrificed. 
3 The animal could be rendered hypertensive. 
4 It was hoped to answer the question: In what phase of the 
cardiac cycle does the heart stop at death? Feigenbaum, et al, 
(1968) and Schroeder, et al, (1969) had suggested that this was 
in the diastolic phase, while Maron, et al, (1977) found close 
correlation with the systolic dimension. 
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M-mode echocardiography was performed using the equipment already 
described, but with the substitution of the 2.25 MHz transducer by 
a 5 MHz Smith Kline and French, non-focussed paediatric transducer. 
To ensure good transducer contact an area over the right chest 
wall was shaved at the level of the third and fourth interspaces. 
The dog was placed on his left side with limbs extended and the 
transducer placed in the third or fourth interspace at the right 
sternal border (fig 32) • 
All animals were anaesthetised for the procedure with a small 
amount of intravenous sodium pentobarbitone. Echocardiography is 
possible to perform in conscious dogs, but as studies had to be 
carried out in a clinical area it was necessary to transport the 
animals whilst asleep. 
Exceptionally high qua1ityechocardiograms were readily obtained on 
all animals. Posterior left ventricular wall thickness was measured 
in end diastole and systole, (Sahn, et a1, 1978), at the point where 
the epicardial marker was identified (fig 33). 
Electrocardiography 
Simultaneous electrocardiographic tracing was obtained via 
electrodes placed on shaved areas of three limbs. 
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Hypertension Induction 
This procedure was performed under strict aseptic conditions with 
the animal anaesthetised by sodium pentobarbitone, 30 mg/kg, 
intravenously followed by tracheal intubation and subsequent 
respiration maintained via a respirator using an air/oxygen mixture. 
Both kidneys were identified via a mid-line laparotomy. The right 
kidney was removed after appropriate haemostatic procedures. Following 
removal of perirenal fat and connective tissue and division of the 
capsular anastamotic vessels, the left kidney was wrapped in cellophane, 
which had previously been immersed in alcohol and then warm saline. 
This was then secured with a loose ligature, so that no compressive 
effect was exerted on the renal vessels or ureter. This procedure 
was based on the one-kidney, wrap-nephrectomy model of Page (1939). 
Intra-arterial blood pressure was measured at all times with the 
animal in the anaesthetised state, recognising that this may have 
resulted in artificially high levels. Blood pressure was recorded 
from the femoral artery via a Statham transducer and a Grass multi-
channel recorder. 
Cardiac Surgery 
Using the same anaesthetic procedure a left thoracotomy was performed. 
The pericardium was opened and a stainless steel disc (4 x 4 mm) 
was sutured on to the epicardial surface of the posterior left ventricle 
5 mm below the inferior border of the left auricle. The pericardium 
was closed and the chest wound closed 'in layers after full lung 
inflation. 
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Apart from an accidental nick of the left anterior descending 
coronary artery in one dog, which responded to pressure - no 
intra-operative complications resulted, either in the chest or the 
abdomen. 
Experimental Animals 
Five, male, mongrel dogs obtained from Sydney University Animal House 
took part in the study. 
Animals were sacrificed by an overdose of anaesthesia upon completion 
of the study and the chest immediately opened and the heart removed. 
The pericardium was opened and the metal marker identified. At this 
point wall thickness was measured, using the same measurement probe 
previously described (fig 28 ). The hearts, emptied of blood, were 
then wrapped in moist gauze swabs and the measurement was repeated 
after 6 hours. 
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Results 
Blood Pressure 
The mean baseline blood pressure of 143.8/81.6 ± 6.50/2.19 mmHg rose 
to 202/111 ± 10.95/5.48 mmHg (p < 0.001) after a mean period of 
6.6 ± 4.2 weeks. This rise in blood pressure was seen in all animals 
at the end of the first three days after wrap nephrectomy. One dog (4) 
had to be sacrificed after only eight days because of terminal uraemia. 
Echocardiographic and direct measurements, together with blood 
pressure, are shown in table 22. Interestingly, the marked degree of 
systolic wall thickening during the cardiac cycle seen in humans is not 
present in the dog heart. The diastolic echo measurements were by and 
large about 10% less than the direct measurement, when the heart was 
empty of blood. The systolic dimension was between 5 and 10% greater. 
An interesting finding and worthy of note was the increase in 
posterior left ventricular wall thickness during the six hour period 
after death. This increase - 4.7 ± 0.71 rom - was highly significant 
(p < 0.001). 
Discussion 
The degree of hypertrophy following hypertension induction was 
disappointing and this perhaps casts some doubt on the validity of 
assessing echocardiographic sensitivity in view of the small numbers 
presented here. Having said that, however, the absolute accuracy of 
the technique was again confirmed with results very similar to those 
of Mashiro, Nelson and Cohn, et al, (1976) and Salcedo, et al, (1979) 
who only reported end-diastolic echocardiographic measurements and 
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direct measurement immediately upon death. 
In the human heart the left ventricular free wall thickens 
considerably during systole. Maron, et aI, (1977), in an echocardiographic 
necropsy study of patients with asymmetric septal hypertrophy found 
that the abnormal septal free wall ratio of > 1.3 during life was 
not present at autopsy. This was explained by an increase in post 
mortem left ventricular wall thickness and it was concluded by the 
authors that hearts must therefore stop in systole. This increase 
in post mortem wall thickness and the close correlation with the 
echocardiographic systolic measurement has been confirmed by Larkin, 
et aI, (1979). However, the findings in dogs suggest that the heart 
does not stop in systole, but rather that left ventricular wall 
thickening occurs in the first few hours after death in a rigor process. 
The considerable systolic thickening in human hearts is not seen in 
the dog left ventricle and, for this reason, there is no correlation 
between the echocardiographic systolic measurement of left 
ventricular wall thickness and the post mortem measurement at 
six hours in the dog. In the human, however, it is suggested that 
the wall thickening which occurs after death quite coincidentally 
corresponds with the echocardiographic systolic measurement 
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CHAPTER TWELVE B M - MODE ECHOCARDI OGRAPHY IN HYPERTENSION 
"Echocardiography identifies anatomic and functional cardiac 
abnormalities in a large percentage of asymptomatic hypertensive 
subjects before abnormalities are detected by ECG or chest x-ray." 
Savage, et aI, 1979. 
"Hypertensive heart disease can be recognised by echocardiography 
as a continuum from an otherwise normal heart to left ventricular 
hypertrophy." 
Dunn, et aI, 1977. 
Echocardiographic Measurement of Posterior Left Ventricular Wall 
Thickness in Normotensives and Borderline Hypertensives 
In established hypertension cardiac hypertrophy appears to have a 
close relationship with the level of the systemic arterial pressure 
and this later stage of the process has been extensively studied 
(Frolich, Tarazi and Dustan, 1971; and Frolich, 1977). By 
contrast there have been few studies of possible hypertrophy in the 
earlier stages of the condition, particularly in borderline 
hypertension. 
The recent advent of non-invasive techniques, particularly 
echocardiography, has provided a reliable and accurate method for 
the measurement of ventricular wall thickness. 
M-mode echocardiography was performed in normotensives and in 
borderline individuals before and upon completion of the six month 
placebo-controlled trial of atenolol. 
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Methods 
Echocardiograms were performed in the manner already described using 
the same equipment and measurement technique. Studies were repeated 
in hypertensive subjects after the six month placebo-controlled 
trial of atenolol. 
Results were analysed using Student t Test for paired and non-paired 
data and analysis of variance. 
Results 
Posterior left ventricular wall thickness was slightly increased in 
normotensive individuals, but this difference was not statistically 
significant (8.2 ± 0.65 mm vs 7.7 ± 0.87 mm; NS). Septal thickness, 
however, was significantly greater in normotensives (8.9 ± 1.49 mm 
vs 8.1 1 1.04 mm; P < 0.05). The values for posterior wall and 
septal thickness were not significantly different in hypertensive 
individuals following randomisation for the six month placebo-
controlled trial of atenolol. At the end of six months, however, 
posterior wall thickness was unchanged in atenolol-treated 
subjects (7.75 ± 0.92 mm vs 7.75 ± 1.18 mm; NS), but had increased 
in the placebo group (7.70 ± 0.84 mm vs 8.54 ± 0.83; P < 0.01). 
Similarly there was a significant increase in septal thickness in 
placebo subjects (8.0B ± 0.99 mm vs 8.94 ± 1.41; P < 0.05), but no 
increase in the actively .treated group (B.17 ± 1.11 mm vs B.21 ± 1.3B mm; 
NS). 
No correlation was found between 24 hour intra-arterial systolic 
and diastolic arterial pressure and septal and posterior wall thickness. 
(Fig 34) . 
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Data were further analysed by extracting echocardiographic values for 
ventricular and septal thickness of the 7 individuals with 
electrocardiographic evidence of left ventricular hypertrophy. 
Mean posterior wall thickness was 7.9 ± 1.06 mm in the group with 
electrocardiographic criteria but was not significantly different 
from the remaining 23 with non-hypertrophy (7.6 ± 0.80; NS). 
Findings were similar for septal thickness (8.1 ± 0.69 vs 8.1 ± 0.35 rom 
respectivelYi NS). 
Influence of the Autonomic Nervous System on Posterior Wall and 
Septal Thickness 
Studies in young spontaneously hypertensive rats have shown that 
cardiac and vascular hypertrophy occur before the blood pressure 
rise (Sen, Tarazi and Khairallah, et aI, 1974 and Yamori, et aI, 
1979). The precise reason for these appearances is unclear, but 
Safar, et aI, (1979), who found asymmetric septal hypertrophy in 
young borderline hypertensives, have suggested a possible 
abnormality of the autonomic nervous system as a contributory factor. 
It was decided to examine the baroreflex sensitivity of borderline 
hypertensives and compare this with echocardiographically measured 
septal and posterior left ventricular wall thickness. 
Results 
Data were analysed by linear regression analysis and are displayed 
in figures 35 and 36. There was a significant inverse relationship 
between baroreflex sensitivity and septal and posterior wall thickness 
(r=-0.50, r=-0.45respectivelYi P < 0.05). 
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COMPARISON OF ELECTROCARDIOGRAPHIC PRECORDIAL AND ORTHOGONAL 
VOLTAGE WITH POSTERIOR WALL AND SEPTAL THICKNESS MEASURED 
BY M-MODE ECHOCARDIOGRAPHY 
Various authors have described conflicting findings in their 
comparison of electrocardiographic and vectorcardiographic 
determinants of left ventricular mass and hypertrophy with more 
direct methods such as biplane angiography or echocardiography. 
On balance, however, the relationship has been poor except in 
the presence of unequivocal left ventricular hypertrophy 
(Carter and Estes, 1964). 
There are no reported studies in borderline hypertension regarding 
a possible correlation between electrocardiographic precordial 
and orthogonal voltage and echocardiographically determined septal 
and posterior left ventricular wall thickness. 
Results 
Data were compared by linear regression analysis. No significant 
correlation was found between the sum of the maximum R + S in the 
precordial leads of the 12-lead electrocardiogram of borderline 
hypertensives when compared to the values for septal and posterior 
wall thickness (r = -0.009 and r = 0.087, respectively; figure 39 
and 40) . and this also applied to normotensives figure 37 and 38 
The maximum Frank lead QRS vector, Vf was also compared to the 
echocardiographic dimensions of septal and posterior wall thickness, 
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but results were similar to the electroGardiographic comparison 
(r -0.1 and r = -0.2, respectively; figure 41 and 42) • 
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APPENDIX II 
SIDE EFFECTS QUESTIONNAIRE 
Please ring appropriate answer, or insert required number, 
eg Age 23 years 
1 Age last birthday 
2 Have you recently been bothered by unsteadiness, 
lightheadedness or faintness? 
YES 
3 Do you now feel more sleepy during the day? 
YES 
4 Do you sleep right through the night? 
YES 
If yes, proceed to question 6. 
5 Have you always had trouble sleeping? 
YES 
6 Do you feel depressed? 
YES 
7 Have you recently noticed any weakness in the 
limbs? 
YES 
8 Do you often have any discomfort in the chest? 
YES 
9 Do you feel short of breath? 
(Please ring only one) 
years 
NO 
NO 
NO 
NO 
NO 
NO 
NO 
1 On walking or other exertion 
2 While resting 
3 Both at rest and on exertion 
4 Not at all 
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10 Do you find that your bowel habit has changed? 
YES, 
1 The bowels open more frequently 
2 The motions are often loose or liquid 
3 They are both loose and frequent 
4 The motions are harder and more difficult to pass 
NO, 
5 There has been no change 
11 Do you find that you have to rise at night 
to pass urine? 
12 Do you suffer from a dry mouth? 
13 Are you often troubled by a blocked 
or runny nose? 
YES 
YES 
YES 
14 Within the last few months, have you often been 
troubled by vivid dreams or nightmares? 
YES 
15 Within the last few months, have you often 
felt sick or vomited? 
YES 
16 During the last few months, have you had a 
rash? 
YES 
17 How often do you suffer from headache? 
(Please ring only one) 
1 Never 
NO 
NO 
NO 
NO 
NO 
NO 
2 Less than one each month 
3 Less than one per week 
4 1 - 6 per week 
5 One or more per day 
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18 Please insert details below of tablets, powders, or 
medicines you are taking, eg aspirin, APC, laxatives, 
vitamins, or other tablets from your own doctor, NOT 
blood pressure tablets: 
Amount NAME COLOUR taken (if known) per day 
1 
2 
3 
4 
5 
6 
19 Have you been bothered recently with sore, 
irritated or gritty eyes? 
YES 
During sexual intercourse are you troubled: 
20 by failure to sustain an erection? 
21 by failure to ejaculate? 
1 
2 
3 
1 
2 
3 
NO 
YES 
NO 
UNKNOWN 
YES 
NO 
UNKNOWN 
22 Has your inclination for sex during the 
last few months been: 
1 UNCHANGED 
2 INCREASED 
3 DECREASED 
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APPENDIX III 
The data comprised R + S values fo~ individual subjects 
on various occasions. 
The study desi~n was such that values were replicated on 
the various days, so that the value for subject i m period k of day j 
was represented symbolically by xijk. 
An additive model 
xijk = a + Si + yij + ~ijk 
provided an adequate description, where: 
a = overall constant level for all subjects on all 
occasions, 
Si = adjustment of subject i, 
yij = further adjustment for subject i on day j, 
~ijk = residual effect, further adjusted for period k, for 
subject i, on day j. 
Thus the model involved successively adjusting for the effect of: 
a) Overall average (for al I subjects at all times), 
b) Subject effect (at all times), 
c) Subject/day interaction. 
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DISCUSSION 
It was Sir George Pickering who said, when discussing hypertension, 
that you never define, but describe the quantity. He, with others 
(Kannel, et al, 1969 and Kannel, et al, 1970), also emphasised that 
blood pressure is a continuous physiological variable without any 
dramatic cut-off point at which morbidity and mortality suddenly 
increase and at which juncture the term hypertension can be safely 
used. 
The most commonly used definition for the term is that described by 
Peart (1981) as a blood pressure level which is associated with 
increased morbidity and mortality at some future time compared with 
the whole population. This definition is eminently suitable for 
the epidemiologist, depending as it does on large numbers and 
usually based on one casual cuff blood pressure reading. It has, 
however, little application in the clinical setting where the 
prognostic significance of a single, casual recording of blood 
pressure must be balanced against the repeat reading which has 
settled with rest, or when the doctor has left the room. Although 
Smirk, Veal and Alstad (1959) reported that life expectancy was 
more closely related to basal, rather than casual, blood pressure 
the overwhelming epidemiological opinion is that the casual reading 
is all important, (Kannel, Sorlie and Gordon, 1980). It is possible, 
however, that by virtue of the large numbers involved in most 
epidemiology studies that those with blood pressure "lability" are 
submerged in the statistical analysis by the large numbers who have 
established elevation of blood pressure. It should also be stressed 
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that for the number of patients whose blood pressure falls on 
re-checking an equal number sustain a subsequent rise (Hawthorne, 
Greaves and Beevers, 1974), so that the average blood pressure of 
the community is unchanged on re-checking. Subjects who display 
so-called "lability" of blood pressure have been found to have little 
evidence of significant end-organ effects or electrocardiographic 
left ventricular hypertrophy (Stokes, MacCarthy and Frost, 1981) and 
many of these people in future years do not achieve blood pressure 
levels that are normally treated (Julius, 1977). However, Harlan, 
Oberman and Mitchell, et ai, (1973) in a 30 year longitudinal study 
of united States Navy airmen found that the higher the baseline 
blood pressure then the higher it was 30 years on. Despite this 
somewhat obvious observation, however, the 30 year pressure 
relationship only applied to those with baseline systolic pressures 
of greater than 160 mmHg. The borderline individuals provided a 
difficult prognostic problem. 
Borderline hypertension in the young has attracted wide investigative 
interest as many workers believe that this period of "labile" blood 
pressure with its attendant features of tachycardia, raised cardiac 
output and autonomic dysfunction may herald the onset of the hyper-
tensive process (Julius and Schork, 1971), while others have dismissed 
the concept as being a manifestation of the defence reaction (Pickering, 
1972). It should be remembered that all previous studies of the 
condition have by and large measured blood pressure indirectly, and 
if direct measurement has been employed this has been in the somewhat 
frightening environs of physiology laboratories. There is therefore 
little information on blood pressure behaviour at times in the day 
when the doctor is not present, although Julius, et ai, (1974) found 
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that blood pressure of borderline hypertensives did fall when 
measured at home. Similarly, apart from the normotensives in 
Julius' home blood pressure study (1974) little information is 
available regarding the behaviour of blood pressure in the normotensive 
throughout a 24 hour period. 
In view of these controversies and inconsistencies a study of 24 hour, 
continuous, intra-arterial ambulatory monitoring in young normotensive 
and borderline hypertensive men was undertaken in this study in order 
that blood pressure patterns and levels might be determined and so 
that blood pressure variability might be examined. 
Obsessional care was taken to accurately categorise subjects according 
to their blood pressure status. Indirect, office blood pressure was 
measured by a random zero sphygmomanometer according to recommendations 
of the Australian National Blood Pressure Study (Abernethy, 1974) over 
a three month lead-in period. The office blood pressure readings were 
complemented by home blood pressure recordings after a period of 
intensive training. 
As far as possible therefore subjects were accurately labelled as 
either normotensive or borderline hypertensive according to criteria 
already described. The 24 hour systolic and diastolic arterial pressure 
of borderline hypertensives was greater than their normotensive counter-
parts. Despite the relative mildness of office blood pressure elevation 
in borderlines the difference in global 24 hour intra-arterial levels 
between them and normotensives was statistically highly significant. 
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On analysis of the data on an hourly basis throughout the 24 hour 
period the bimodal pattern of blood pressure was identical for both 
groups. The dramatic fall in night-time blood pressure during sleep 
was also apparent in both normotensive and hypertensive alike, as 
was the pronounced early morning rise. 
Blood pressure was lowest around 0200-0300 hours and began to rise 
before waking. The controlling mechanism for this apparent circadian 
blood pressure rhythm is unknown, but it is well recognised that 
adrenal cortico-steroids and mineralocorticoids exhibit a diurnal 
variation. The information on plasma catecholamines is less clear. 
The further rise in blood pressure around the time of waking has 
been attributed to the arousal or defence reaction. It is extremely 
difficult to determine when the precise moment of waking occurs. 
Subjects in the study were asked to press their event marker button 
on waking and again on rising. Not surprisingly most omitted to do 
this immediately on coming to, so that the waking and getting up 
events were often very close together. The analysis technique used 
in this study did not permit substantial separation of these events 
in most instances. It is now generally agreed that awakening probably 
is a gradual process in most individuals, beginning in the period of 
rapid eye movement sleep. A combined study of electroencephalography 
and continuous intra-arterial blood pressure recording might contribute 
to further understanding, but may also potentiate the defence 
reaction, as any such study would naturally have to be performed in 
a hospital environment. 
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Day-time blood pressure for both groups was significantly higher 
than night-time levels and corresponded closely to office and home 
blood pressure readings although displaying no actual correlation. 
Despite the significant blood pressure difference between normo-
tensives and hypertensives it has recently been found that in a 
24 hour period normotensives may exceed pressure levels that are 
normally regarded as hypertensive. Using an improved analysis 
technique, employing beat to beat recognition, Hunyor, Larkin 
and Roffe, et aI, (1982) demonstrated that systolic pressure of 
160 mmHg and diastolic pressure of 100 mmHg was exceeded by most 
normotensives at some point in the 24 hours, but for significantly 
shorter periods than borderline hypertensives. This finding is 
entirely consistent with the findings of Watson, et aI, (1979) who 
found that physical activity strongly influenced arterial pressure 
variability. Peaks of blood pressure were observed in this study in 
which normotensives and borderline hypertensives engaged in normal 
everyday pursuits, thereby strengthening the belief that all blood 
pressures are indeed labile. 
The finding of blood pressure lability was not entirely unexpected, 
but excessive blood pressure variability has been described in 
borderline hypertension (Birkenhager, et aI, 1968). The difficulty 
in determining blood pressure variability is illustrated by examining 
data from the Framingham Study in which the coefficient of variation 
of blood pressures measured in triplicate showed almost no correlation 
with subsequent measurements (Gaylarde, 1982). The authors of the . 
study, however, (Kannel, et aI, 1980) found that variability rose with 
increasing mean blood pressure, although this has not been confirmed 
by others. 
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There is thus uncertainty regarding the best index of blood pressure 
variability and that which is statistically most relevant and powerful. 
Few studies have been done of intra-arterial pressure variability, but 
Watson, et ai, (1979) and Ogawa, et ai, (1981) employed standard 
deviation of the mean. Obviously standard deviation is directly 
correlated to the value of the mean in any gaussian distribution, but 
it was felt to be a suitable index of variability for this study in 
view of the relatively small difference in mean blood pressures between 
groups. 
Despite some isolated periods of increased variability in the 24 hours, 
by and large systolic and diastolic arterial pressure variability of 
borderline hypertensives was not significantly different from normo-
tensive controls in this study. 
The observation of widely fluctuating blood pressure in the baro-
receptor denervated dog (Cowley, et ai, 1973) has reinforced the 
view that the baroreflex arc is important in buffering excessive 
swings of blood pressure. Although blood pressure in the dogs was 
extremely labile none subsequently developed hypertension, thereby 
suggesting that the baroreceptor mechanism had little or no role in 
the initiation of hypertension. There is now, however, accumulating 
evidence that baroreceptor denervation in man does result in hyper-
tension after a period of blood pressure fluctuation (Sleight, 1979). 
Despite some reservations and doubts it is now generally accepted 
that baroreflex function is impaired in established hypertension 
(Gribbin, et ai, 1971 and Kerner, et ai, 1974), while more recent 
evidence suggests that impairment is also present in young, borderline 
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hypertensives (Takeshita, et aI, 1975 and Eckberg, 1979). The 
latter finding, however, has been disputed by others (Julius, et aI, 
1975) and even by Eckberg (1979) who found normal baroreflex 
sensitivity in "milder" borderline hypertension. 
In view of these inconsistencies and controversial findings 
baroreflex sensitivity was measured in normotensives and borderline 
hypertensives using the universally accepted method of Smyth, et aI, 
(1969). Baroreflex sensitivity was found to be diminished in borderline 
hypertensives compared to normotensives and results were in close 
agreement with those of Takeshita, et aI, (1975). There was no 
correlation in this study between systolic arterial pressure and 
baroreflex sensitivity as reported by other workers (Watson, et aI, 
1979). This may be due to the fact that subjects in this study were 
comparable to Eckberg's milder borderline hypertensives. 
The finding of reduced baroreflex sensitivity was not reflected by 
significantly increased blood pressure variability in borderline 
hypertensives and this is perhaps not altogether surprising bearing 
in mind the relative mildness of blood pressure elevation and the 
young age of the individuals. Long-term longitudinal studies are 
obviously desirable in this area as data presented here do not permit 
any firm pronouncement on the role of the baroreflex arc in the 
initiation of the hypertensive process. The discovery, however, of 
a close negative correlation between baroreflex sensitivity and 
thickness of the interventricular septum and posterior left ventricular 
wall, in the absence of left ventricular hypertrophy, does tend to 
support Eckberg's hypothesis (1979) that borderline subjects with 
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depressed baroreflex responses are more likely to develop hypertensive 
cardiovascular disease. 
It is no great consolation to a young man to be told that the biggest 
benefits in hypertension at any stage of treatment are to be found in 
those subjects over 50 years and with diastolic pressures in excess 
of 100 mmHg, who already have signs of end organ damage. On purely 
theoretical grounds lowering of the blood pressure before hypertension 
develops offers the strongest possible approach to prevent future 
hypertension. This policy would, of course, entail a considerable 
financial burden on any health service, not to mention the possible 
psychological problems encountered by treated individuals. The 
question of possible long-term, harmful drug side effects in an 
otherwise healthy young individual would also loom large. At the 
present time most hypertensive risk factors are weak and as yet 
unproven, although a recognised major predictor is the initial blood 
pressure level itself. 
In order to assess the effectiveness and efficacy of antihypertensive 
therapy in a young, borderline hypertensive population, the 
~-adrenoreceptor blocker, atenolol, was employed during a six month 
placebo-controlled trial in this study. 
It was hoped to examine a number of questions: 
1 Can effective blood pressure lowering be achieved in mild, 
borderline hypertensives? 
2 What is the incidence and nature of side effects encountered? 
3 Does the p-adrenoreceptor-blocker, atenolol, indeed have an 
effective 24 hour antihypertensive action? 
193 
4 Is the blood pressure lowering action of ¥-blockers achieved by 
modification of the baroreflex mechanism? 
5 Do borderline hypertensives have hypersensitive B-adrenergic 
receptors? 
The antihypertensive e£fectiveness of atenolol was amply demonstrated 
by office and home blood pressure readings during the six month trial 
period. There was a significant fall in both systolic and diastolic 
arterial pressure compared to both pre-treatment and placebo levels. 
Although there was also a reduction of blood pressure in the placebo 
group this did not reach statistical significance. Interestingly, 
this fall in placebo-group blood pressure was not evident when the 
record of 24 hour intra-arterial blood pressure was examined. This 
observation lends support to the view that the fall in blood pressure 
during repeated cuff measurements is not due to regression towards 
the mean or a placebo effect, but rather results from damping down 
of the defence reaction (Pickering, 1972). 
The results of this study therefore demonstrated, for the first time, 
quite conclusively, that significant lowering of the blood pressure 
can be achieved by ¥-adrenoreceptor blockade in young, borderline 
hypertensives. 
With the prospect of life-long drug therapy, any metabolic 
consequences of long-term administration assume great importance. 
The need for additional drug therapy for hypokalaemia and hyperuricaemia 
in certain instances of diuretic therapy and the recognised side effects 
of methyl dopa made these agents less than ideal and prompted the use 
of a ~-adrenoreceptor blocking agent. This decision, however, does 
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not imply a belief that ~-blockers are free of side effects. The 
fact that this is not the case is illustrated by results from the 
MRC Working Party on Mild to Moderate Hypertension (1977) in which 
patients treated with propranolol had an increased incidence of 
symptoms of Raynaud's phenomenon, dyspnoea, skin disorders and 
lethargy, and impotence in males, compared to placebo controls. 
The numbers in this study were, of course, small, but there were no 
drop-outs and drug compliance was excellent. A side-effects 
questionnaire was administered upon completion of the therapeutic 
period. This was based on that used in the Australian National Blood 
Pressure Study (Bauer, et al, 1978). There were no complaints of 
Raynaud's phenomenon - although it should be stressed that the trial 
was conducted in a warm climate with a cardioselective ~-blocker. 
Dyspnoea, with wheeze, was reported by two individuals on atenolol, 
both of whom had suffered from childhood asthma. In one there was 
a slight reduction from his baseline FEV1, but this did not 
necessitate him stopping therapy. It was not the remit of this 
study to assess physical fitness, but many of the subjects participated 
in regular sports and none volunteered symptoms of exercise limitation. 
Importantly in youn91 healthy men there were no reports of interference 
with sexual function. 
The reasons for using a ~-blocker in the study have already been 
described. It was felt that a cardioselective agent with a once-a-day 
dose would be desirable and atenolol (leI 66.082, Tenormin) was 
selected in a dose of 100 mg. In brief, the important properties of 
the compound are (a) cardioselectivity, (b) lack of intrinsic 
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sympathomimetic properties (c) lack of membrane-stabilizing 
effect and (d) inability to cross the blood-brain barrier. 
Atenolol has been reported to have an effective 24 hour antihypertensive 
action with a once daily dose (Floras, 1979), but this was not 
confirmed by Millar-Craig, Kenny and Mann, et ai, (1979). The 
effective 24 hour antihypertensive action of atenolol was quite 
striking in this study of borderline hypertensives for both systolic 
and diastolic arterial pressure. There was no effect on blood 
pressure variability, however. Despite an effective 24 hour anti-
hypertensive action, the effect on heart. rate slowing was not maintained 
until the end of the 24 hour period. 
These results indicate that atenolol is an effective antihypertensive 
drug in borderline hypertension, with a full 24 hour action, in a 
once-a-day dose and with an extremely low incidence of side effects. 
The lack of complete 24 hour reduction of heart rate perhaps calls 
into question its possible once-a-day effectiveness in the control 
of anginal symptoms. 
The antihypertensive mechanism of P-blockade is not fully understood, 
but Pickering, Gribben and Peterson, et ai, (1972) and Eckberg, 
Abboud and Mark (1976) have demonstrated that intravenous propranolol 
increased the sensitivity of the baroreceptor reflex. This raises 
the possibility that this mechanism may have a role in the anti-
hypertensive action of ~-blocking agents. 
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It had already been demonstrated that baroreflex sensitivity was 
decreased in borderline hypertensives when compared to age-matched 
normotensive controls. After chronic ~-blockade repeat assessment 
of baroreceptor function in borderlines showed that there had been 
a significant increase in sensitivity, reaching normotensive values. 
These observations are consistent with those of Watson, et al, (1979) 
who found increased sensitivity with chronic propranolol, but only 
in hypertensive subjects below the age of 40. Results from these 
authors are also in agreement with this study regarding the lack of 
correlation between fall in blood pressure and alteration of baro-
reflex sensitivity. This observation does not lend support to the 
theory that increased baroreflex sensitivity is a major contributor 
to the antihypertensive action of ~-adrenoreceptor antagonists. It 
seems likely that the apparent increase in sensitivity after 
~-blockade is a function of the achieved heart rate, as Pickering, 
et al, (1972) have demonstrated that baroreflex sensitivity is 
inversely related to pulse interval. These observations point to 
a critical balance between parasympathetic tone at the sino-atrial 
node in determining baroreflex sensitivity and the response to 
~-adrenoreceptor blockade. 
Julius and Esler (1975) have postulated that borderline hypertensives 
have hyperresponsive p-adrenoreceptors as part of a "hyperkinetic" 
state. Takeshita, et al, (1978) assessed ~-adrenoreceptor 
responsiveness to intravenous propranolol in young, tachycardic, 
borderline hypertensives and decided that there was no evidence to 
support a theory of p-receptor hypersensitivity in borderline hyper-
tension. A similar conclusion can be drawn from this study, where 
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at no time did heart rate differ significantly between normotensives 
and borderline hypertensives and although ¥-blockade increased baro-
reflex sensitivity to normotensive values it did not significantly 
exceed those values. These findings support the opinion that there 
is no firm evidence to suggest a hypersensitivity of ~-adrenoreceptors 
in borderline hypertension. 
Increased arterial pressure is obviously the major stimulus to 
cardiac hypertrophy in hypertension. However, it has been suggested 
that other factors may precipitate the process and this has been 
demonstrated by Yamori, et aI, (1979) in the pre-hypertensive stage 
of spontaneously hypertensive rats. In human, borderline hypertension 
Safar, et aI, (1979) have reported an increased incidence of asymmetric 
septal hypertrophy - findings corroborated by Culpepper, Hutcheon and 
Arci11a, et aI, (1979) in hypertensive children. 
There is little doubt that although the major responsibility for cardiac 
hypertrophy in hypertension is the increased pressure load, the findings, 
both in animal and human studies, of hypertrophy at an early borderline 
phase of the condition raise the possibility that neurohumoural and 
genetic factors may have a role and that muscular hypertrophy may only 
be part of a generalised phenomenon in systemic hypertension involving 
the vasculature and the myocardium. This theory poses the interesting 
question: Can myocardial hypertrophy be prevented by blood pressure 
lowering at an early stage, and does it regress with treatment7 
Despite obvious limitations of sensitivity, and to a lesser extent 
specificity, (Romhilt, et aI, 1969), the electrocardiogram is a 
valuable tool for the diagnosis of left ventricular hypertrophy. 
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Although close correlation has been reported between electrocardio-
graphic voltage criteria and hypertrophied hearts at post mortem, 
no correlation has been demonstrated in the absence of hypertrophy 
(Sjogren, 1970). 
The majority of electrocardiographic criteria of left ventricular 
hypertrophy are based on precordial voltage amplitude (Sokolow and 
Lyon, 1949 and McPhie, 1958), but in the young male increased 
precordial voltages are often found (Manning and Smiley, 1964 and 
Kilty and Lepeschkin, 1965~ although it should be stressed that 
concurrent blood pressure data is sadly lacking. 
The relationship between body build and electrocardiographic voltage 
hypertrophy in the young male is controversial. In the clinical 
setting the finding of high precordial voltages in the electrocardiogram 
of the young asthenic individual is well recognised, but Simpson, et aI, 
(1978) found no correlation between electrocardiographic appearances and 
body habitus. 
Physical fitness is also known to result in a variety of electrocardio-
graphic changes, including voltage left ventricular hypertrophy, in 
athletes (Zoneraich, Zoneraich and Rhee, et aI, 1979). 
Despite the difficulties alluded to, the electrocardiogram, with 
proper and careful use, can perform an unique role in screening large 
numbers for left ventricular hypertrophy. The importance of early 
hypertrophy detection has already been discussed and for this reason 
it was decided to determine the prevalence of electrocardiographic 
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left ventricular hypertrophy in a young male population in whom 
accurate blood pressure and body build data was available. 
A striking feature of the survey was the sheer number of young men 
.with a blood pressure "abnormality" - 26% of the total 913 individuals. 
This figure is in close accord with those found by others (Julius, 
et aI, 1974) and illustrates the size of the problem of mild hypertension 
in the young, emphasising the need to determine identification parameters 
for those who will ultimately go on to established hypertension. 
Electrocardiograms were coded according to the Minnesota Code 
(Blackburn, et aI, 1960) with electrocardiographic left ventricular 
hypertrophy being represented by MC3-1, and, or MC3-3. Blackburn, 
Parlin and Keys (1966) have found that these criteria compare 
favourably with other voltage criteria which have been more extensively 
studied. Approximately 14% of all individuals fulfilled Minnesota Code 
criteria for hypertrophy. Only 11% of normotensives fulfilled criteria, 
but almost one in three hypertensives were found to have electrocardio-
graphic evidence of left ventricular hypertrophy. Findings in the 
borderline group were comparable to those of Stokes'. (1981) study of 
labile hypertension where no increase in hypertensive end organ effects 
was noted. 
No significant difference in blood pressure was found, within blood 
pressure categories, between hypertrophy and non-hypertrophy groups. 
No correlation was found between body habitus, measured by quetelet 
index, and electrocardiographic criteria, except in the borderline 
group. Overall hypertensives were significantly heavier than 
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normotensives, but in the borderline category hypertrophy subjects 
were significantly more asthenic than their non-hypertrophy counter-
parts. This finding raises the possibility that in only this group 
did body habitus influence electrocardiographic appearances. 
The discovery of a significantly increased incidence of electrocardio-
graphic left ventricular hypertrophy in young hypertensives, with 
comparatively mild blood pressure elevation is of considerable importance. 
It adds support to the view that in a population study cardiac hyper-
trophy may already be present in the earliest stage of hypertension. 
The absence of a difference in arterial blood pressure between hyper-
trophy and non-hypertrophy groups is consistent with the theory that 
factors other than height of arterial pressure may contribute to the 
development of cardiac hypertrophy. 
Population study data showed no difference in blood pressure between 
hypertrophy and non-hypertrophy hypertensives. Although there was a 
difference in office blood pressure readings between hypertrophy and 
non-hypertrophy borderline hypertensives in the laboratory this just 
failed to reach statistical significance. However, when an analysis 
of 24 hour intra-arterial blood pressure recordings was performed it 
was found that there was a highly significant difference between 
groups, with hypertrophy individuals maintaining higher arterial 
pressures for considerably longer periods in the 24 hours compared 
to non-hypertrophy counterparts. 
This exciting discovery may, at least in part, explain the observation 
of lack of significant difference in indirectly measured blood pressure 
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between electrocardiographic hypertrophy and non-hypertrophy groups. 
It is clear that the hearts of subjects in this study with electro-
cardiographic evidence of left ventricular hypertrophy were exposed 
to increased afterload for a considerably longer period in any 
24 hours period. Perhaps these are the individuals who proceed to 
established hypertension and anatomical myocardial hypertrophy. These 
data may also help explain the many discrepancies between the level 
of arterial pressure and the occurrence of signs of cardiac hypertrophy, 
or their reversal by therapy (Helmcke, Schneckloth and Corcoran, 1957 
and Farmer, Gifford and Hines, 1963). 
The appearance of electrocardiographic left ventricular hypertrophy 
in the established hypertensive is an ominous harbinger of future 
cardiovascular events (George and Dollery, 1972). The prevention, 
or reversal of the process at an early stage offers the best theoretical 
grounds for subsequent reduction of morbidity and mortality. In this 
study electrocardiograms were performed before and upon completion 
of a six month period of placebo-controlled antihypertensive therapy. 
As previously mentioned there was no significant difference in 
precordial voltages of borderline and normotensive groups. At the 
end of six months antihypertensive therapy precordial voltage was 
significantly reduced in subjects treated with atenolol and had 
remained unchanged in the group given placebo. The possible signi-
ficance of these findings will be discussed together with echocardio-
graphic data overleaf. 
In assessing any hypertensive individual's response to antihypertensive 
therapy it is desirable, and indeed important, to be aware of the 
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normal variability present in the electrocardiogram, particularly in 
the Rand S voltages of the precordial leads. Although significant 
repeat variability had been shown by early workers (Simonson, et ai, 
1949), no study had been undertaken since the introduction of high 
impedance buffer amplifier equipment. These amplifiers effectively 
eliminated skin-electrode resistance which had previously been recognised 
as the major source of variability (Berson and Pipbergeri 1968). 
The presence of significant intra-individual variability has been 
demonstrated in this study, despite stringent efforts to minimise 
all known, remediable causes. The extent of variability was surprisingly 
large, even on a same-day basis and was only reduced by precordial 
electrodes remaining in position between recordings. This has 
demonstrated that the major source of precordial voltage variation 
is due to inaccurate sequential electrode positioning. These findings 
pose further difficulty in the assessment of the hypertensive's 
electrocardiogram and in the interpretation of possible response to 
antihypertensive therapy. The effects of repeat variation, however, 
would be expected to cancel out in group data. 
As previously mentioned a number of authorities have postulated the 
existence of ¥-receptor hypersensitivity in borderline hypertension. 
This supposed increased adrenergic drive, with effects on the heart 
of tachycardia and increased cardiac output has resulted in the 
introduction of the term "hyperkinetic heart syndrome" (Guazzi, et 
ai, 1975). These authors detected a number of electrocardiographic 
changes in such individuals, but it should be pointed out that the 
small number of subjects had initially been referred because of a 
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supposed cardiac abnormality or the finding of an already abnormal 
electrocardiogram. It was presumed that increased sympathetic 
stimulation resulted in T-wave inversion and these changes could 
be reversed by p-blockade. 
Certainly, T-wave inversion was common in this study, with 30% of 
borderline subjects displaying inverted T-waves in lead III. Unlike 
reports from others (Guazzi, et al, 1975) long-term p-blockade had no 
effect on these appearances in this study, further reinforcing the 
view that borderline hypertensives were not exposed to increased 
sympathetic drive. 
Orthogonal electrocardiography, by virtue of its simultaneous 3-lead 
display, offers a number of advantages to the cardiologist. Chief 
amongst these is probably the relative ease whereby the system can be 
adapted for computer analysis by virtue of the reduced information 
required to be stored compared to the conventional 12-lead system. 
Despite this attraction, however, it is little used, although since 
its introduction by Frank (1956) a number of varying claims have 
been made regarding the accuracy of the technique in the diagnosis 
of left ventricular hypertrophy. 
Recently MacFarlane, Melville and Horton, et al, (1981) in a 
comparative computer evaluation of 12-lead and orthogonal 3-lead 
systems, found that the performance of both was very similar in the 
detection of left ventricular hypertrophy in a hospital population. 
Bahler, et al, (1977) in a study of apparently normal young subjects 
found a close correlation between echocardiographic septal thickness 
and the absolute value of the Frank Lead QRS vector (Vf). 
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In this study a close correlation was found between Vf and maximum 
precordial voltage of borderline hypertensives. In addition the 
value of Vf was significantly greater for hypertensives when compared 
to normotensive controls. 
The correlation between Vf and precordial voltage is not unexpected 
as both reflect the spatial magnitude of the heart vector. The 
increased value of Vf in borderline hypertensives is of considerable 
interest, however, as it suggests a possible relationship with the 
level of arterial pressure. This latter observation was reported by 
Gamboa, Hugenholtz and Nadas (1959) who found a close correlation 
between systolic pressure and the maximum QRS vector, albeit at 
considerably higher levels of pressure than seen in this study. 
Little is known about normal orthogonal electrocardiographic 
appearances in the young and there are no previous studies in 
borderline hypertension. Results from this study suggest that more 
information is required as the technique may have a role in the 
investigation of the young hypertensive, with or without computer 
analysis. 
Despite a number of interesting findings it is clear that the 
established electrocardiographic criteria for left ventricular hyper-
trophy are only loosely correlated with blood pressure in borderline 
hypertension. These results are consistent with the observation of 
McPhie (1958) that lesser degrees of left ventricular hypertrophy 
cannot be accurately diagnosed by any criteria described to date. 
It is perhaps somewhat naive however to expect that electrocardio-
graphic hypertrophy is purely a function of muscle bulk. There are 
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suggestions that the process may begin at a cellular electrical level 
with an alteration in the depolarisation pulse through the fibres 
which will subsequently hypertrophy. This is borne out by computer 
analysis of precordial voltage waveforms where a relationship has 
been demonstrated between Rand S wave rise time and left ventricular 
wall thickness in borderline hypertensives (Fischhof and Larkin, 1980). 
The rise time is a difficult parameter to measure, both from chart 
records, because of the small times involved (corresponding to about 
t rom), and by computer, because of the difficulties involved in 
establishing the starting point. Despite this technicality, however, 
the computer analysis of electrocardiographic waveforms may have a 
particular role in the detection of the myocardium's earliest 
initiation of the hypertensive process. 
At best the electrocardiogram is still an indirect method of assessing 
cardiac anatomy. Echocardiography, however, provides a safe, non-
invasive and direct method for the measurement of various cardiac 
dimensions. Examination of the left ventricle is of particular interest 
in the area of hypertension as any increase in systemic arterial 
pressure exerts a direct effect on the left side of the heart by 
virtue of an increased after-load. The description of the anatomical 
accuracy of the echocardiographic measurement of posterior left 
ventricular wall thickness by Feigenbaum, et aI, (1968) heralded the 
possible alternative to the electrocardiogram for the diagnosis of 
left ventricular hypertrophy. 
This assumption was premature as no conclusions about anatomical 
accuracy could be drawn from the Feigenbaum (1968) study because of 
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its serious limitations. Further studies on anatomical accuracy 
were controversial (Schroeder, et aI, 1969 and Maron, et aI, 1977), 
with the main area of disagreement surrounding the phase of the 
cardiac cycle which corresponded most closely to the echocardiographic 
measurement of left ventricular wall thickness. 
Results of this study support the view that the measurement of 
echocardiographic end diastolic posterior left ventricular wall 
thickness corresponds closely to the direct measurement performed 
upon hearts in a state of hypothermic, cardioplegic arrest at open-
heart surgery. The echocardiographic end systolic measurement, not 
diastolic, corresponds with that obtained in the post mortem room. 
Maron, et aI, (1977) also reported this finding and concluded that 
the heart must stop in a systolic phase at death. This is not 
supported by the data obtained in the study of dogs' hearts, however, 
which point to the heart stopping in diastole, but progressive muscle 
thickening occurring over a period of hours after death. 
It had originally been intended to use the dog heart as a model for 
assessing the accuracy of echocardiography in detecting serial changes 
of left ventricular wall thickness in response to surgically-induced 
hypertension. Unfortunately, the project was not a complete success 
owing to the high mortality rate among animals. Echocardiography could 
only be performed in a clinical area and as a result dogs had to be 
transported by wheelbarrow in an anaesthetised state. As a result 
a number succumbed from respiratory arrest during transport either 
to or from echocardiography, leaving few for statistical analysis. 
Although there was a rise in absolute blood pressure, it should be 
pointed out that femoral intra-arterial pressure in the dog rises in 
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the anaesthetised state and no blood pressure data was available on 
the post-operative conscious animal and it may well be that these 
levels were not quite so high. This would be consistent with Page's 
findings (1938) whose animals did not develop hypertension until at 
least three weeks after renal wrapping. The slow development of 
hypertension probably explains the generally small change in posterior 
left ventricular wall thickness in the hypertensive phase. The study, 
however, did confirm, once again, the anatomical accuracy of echo-
cardiography and also helped explain the intriguing question of the 
phase of cardiac cycle at death. 
The availability of an accurate method of measuring cardiac dimensions 
prompted a comparison between electrocardiographic precordial voltage 
and measurements of septum and wall thickness. Previous studies have 
demonstrated an extremely poor relationship between the electrocardiogram 
and measurements of wall thickness during biplane angiography, echo-
cardiography and post mortem, except in the presence of established 
left ventricular hypertrophy (Carter and Estes, 1964). 
In this study of borderline hypertension the comparison between 
electrocardiogram and echocardiograph was disappointing with no 
statistical correlation apparent. The situation was similar when the 
orthogonal maximum spatial vector was compared to septal and posterior 
left ventricular wall thickness. 
Geva, Elkayam and Frishman (1979) in a study of patients with chronic 
systemic hypertension found the sensitivity of electrocardiographic 
criteria for left ventricular hypertrophy to range from 52% to 69% 
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when compared to echocardiographic measurements of left ventricular 
wall thickening but six patients who had increased left ventricular 
wall thickness and normal electrocardiograms were categorised as 
showing mild left ventricular wall thickening. In view of these 
results, and.others, it is perhaps not surprising that no electro-
cardiographic/echocardiographic relationship was present in 
borderline hypertension. This observation does not however, attempt 
to diminish the importance of either technique in the investigation 
of the young hypertensive. Electrocardiographic appearances in early 
hypertension may be independent of muscle mass and it should be stressed 
at this point that uncertainty still surrounds the exact mode of 
production of electrocardiographic phenomena in ventricular hypertrophy. 
Differences in ventricular activation time in borderline hypertension 
may herald the onset of the earliest hypertrophy process. 
No borderline hypertensives in this study fulfilled the commonly 
accepted echocardiographic criteria for left ventricular hypertrophy -
i.e. wall thickness in excess of 11 rum (Feigenbaum, 1976). Indeed 
there was no significant difference between left ventricular wall 
thickness of hypertensives and normotensive controls, while the 
septal thickness of the latter group was actually greater than 
hypertensives. At first sight this might appear to indicate that wall 
thickness was independent of arterial pressure, but after six months 
of placebo-controlled antihypertensive therapy there was a significant 
increase in both septal and posterior wall thickness while these 
dimensions remained unchanged in the group treated with ~-blocker. 
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These results are consistent with the view that cardiac hypertrophy 
is only slowly progressive and there must obviously be a baseline 
value. Measurement of wall and septal thickness may be important 
only as a comparison for future sequential studies, with left 
ventricular wall thickening indicating hypertrophy in progress and 
requiring urgent blood pressure lowering. 
Baseline results from this study do not support Safar, et al's, 
(1979) findings of increased septal thickening in borderline hyper-
tension compared to normotensive controls. In this French study, 
however, subjects were older with higher levels of systemic arterial 
pressure. Septal measurement by echocardiography is not without 
difficulty and false reports of asymmetric septal hypertrophy are 
commonly seen where incorrect transducer positioning has been employed 
(Kotler, Segal, Mintz and Parry, 1977). 
These variables may explain the discrepancies between Safar's (1979) 
findings and those of this study. However, the results of the 
longitudinal study are in accord and indicate that cardiac hypertrophy 
is in progress, while at the same time being countered by blood 
pressure lowering in this phase of borderline hypertension. It will 
be remembered that a similar situation was witnessed with regard to 
the electrocardiogram. 
These findings add further weight to the belief that cardiac 
hypertrophy is already present at the earliest stage of hypertension. 
A number of authors have already reported alterations in cardiac 
performance by echocardiography in established hypertension, before 
the appearances of electrocardiographic appearances, (Dunn, et al, 1975 
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and Savage, et al, 1979) and in pregnancy hypertension (Larkin, 
Gallery and Hunyor, et al, 1980). Many of these parameters, however, 
rely on the extrapolation of one-dimensional M-mode information into 
3-dimensional form, which of course requires assumptions on the true 
elipsoid character of the heart. 
The effect of hypertrophy on myocardial performance has long been 
controversial, but quite recently Marcus, Mueller, Gascho and Kerber 
(1979) have demonstrated that the coronary circulation is adversely 
affected. It was previously proposed that the vascular hypertrophy 
of hypertension is a generalised process involving not only the 
vasculature, but also the myocardium. The inverse relationship 
between baroreflex sensitivity and septal and posterior left ventricular 
wall thickness is consistent with this view and suggests that possible 
structural changes may be present in the carotid body as part of 
generalised vascular hypertrophy in borderline hypertension. Reversal 
of this structural hypertrophy after prolonged p-blockade may be the 
mechanism which resulted in increased baroreflex sensitivity and this 
is in agreement with the findings of Jennings, Korner and Esler (1979) 
who found complete restoration of structural changes after one year of 
antihypertensive therapy. 
Blood pressure reduction in established hypertension reduces future 
morbidity and mortality, but all too often at a stage when the process 
has been long-standing and end organ effects are already present. Far 
better that the condition be identified in the young, asymptomatic 
individual, free of all target organ damage. This study has shown 
that borderline hypertension is a sizeable problem and of course not 
all individuals will proceed to later, established blood pressure 
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elevation. These young people should therefore be screened intensively 
by office and home blood pressure readings over a period of time, while 
having serial electrocardiography and echocardiography performed. In 
those whose blood pressure does not settle with time, or who show 
evidence of developing cardiac hypertrophy by electrocardiographic or 
echocardiographic criteria assessment of baroreflex sensitivity and, 
if available, 24 hour continuous ambulatory, intra-arterial monitoring 
may help to decide those in whom long-term blood pressure lowering 
therapy is indicated. 
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CONCLUSIONS 
1 Hypertension is a common finding in young males. This study 
found a prevalence of 28% of whom 19% fell into the 
borderline hypertension category. 
2 Borderline hypertensives were heavier than their normotensive 
counterparts. 
3 Heart rates of normotensives and hypertensives did not differ 
significantly. 
4 Contrary to the findings of previous studies home blood 
pressure did not significantly differ from office readings. 
5 Throughout continuous monitoring of 24 hour intra-arterial 
systolic and diastolic pressure there was a significant 
difference between normotensives and borderline hypertensives 
for the greater part of the day-long period. 
6 The circadian variation of blood pressure was identical for 
both groups with night-time levels significantly lower than 
those of the waking hours. 
7 Day-time ambulatory, intra-arterial blood pressure corresponded 
closely, but did not correlate with, office and home blood 
pressure. 
8 All blood pressures were noted to be labile, but borderline 
hypertensives did not demonstrate increased variability. 
9 Baroreflex sensitivity was reduced in borderline hypertension, 
but there was no correlation between this impairment of the 
control mechanism and blood pressure variability. 
10 Effective blood pressure lowering was achieved by the 
~-adrenoreceptor blocker, atenolol, in borderline hypertensives 
with minimum side effects. 
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11 Atenolol effectively reduced systemic arterial pressure 
throughout the 24-hour period in a once-a-day dose. 
12 Baroreflex sensitivity increased after six months ~-blockade, 
but the increase was unrelated to the fall in blood pressure. 
13 One in three young men with mild hypertension satisfied 
electrocardiographic criteria of left ventricular hypertrophy. 
14 The relationship between body habitus and electrocardiographic 
criteria of left hypertrophy is weak. 
15 Significant repeat variation of precordial voltage in the 
normal electrocardiogram is of sufficient magnitude to interfere 
with the accurate assessment of serial changes in the individual. 
16 Maximum precordial voltage did not differ between the electro-
cardiograms of borderline hypertensives and normotensives, but the 
24-hour blood pressure of seven hypertensives who fulfilled 
electrocardiographic criteria of left ventricular hypertrophy was 
consistently greater throughout most of the 24-hour period. 
17 During the six month period of placebo-controlled atenolol therapy 
precordial voltage increased in the placebo group, while remaining 
unchanged in actively treated individuals. 
18 Orthogonal electrocardiography correlated closely with 
conventional 12-lead electrocardiography, but neither technique's 
criteria for left ventricular hypertrophy displayed any correlation 
with echocardiographic septal and posterior left ventricular 
wall thickness. 
19 There was no evidence of borderline hypertensive sympathetic 
overactivity based upon heart rate, baroreflex sensitivity and 
electrocardiographic appearances. 
20 M-mode echocardiography is an accurate method for the measurement of 
posterior left ventricular wall thickness when compared to direct 
measurement at open heart surgery and autopsy. 
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21 Septal and posterior wall thickness did not differ between 
borderline hypertensives and normotensive controls, but during 
the six month period of antihypertensive therapy there was a 
significant increase in these dimensions in the placebo group, 
while remaining unchanged in the actively treated group. 
22 The finding of an inverse correlation between baroreflex 
sensitivity and septal and posterior wall thickness supports 
echocardiographic and electrocardiographic data of developing 
cardiac hypertrophy in borderline hypertension. 
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RIVA -ROCCI AND .J(OROTKOJi'F 13 
pre.: :Jure, while the point at which they were suppressed represented 
:w;:; to lic presslll'e . 
• Out ofthe two lines of evolution have developed the modern methods 
of measnring the blood pressure. The first important advance was in 
I Sf)(j by H.ivn.-Rocci, " .. ho inflated a pneumatic cuff on the upper arm 
t l) a pre"sure sufficient to oblitemte the pulse at the wrist. Later 
Y . Recklinghn.usen (1£)01) showed that Riva-Rocci's arm band gave 
{, lTlllle 0 11"l y ltigh l'<.'l tdings and recommended a cuff 10-)5 cm. wide. 
In 1 ~(J5, Korotkoft', a Russian physician, suggested that the sounds 
hcnd on'!' the artery distal to the cuff sho:uld be used as indices of 
systolic and diastolic pressure. Subsequent work showed that those 
sound:; passed through four successive phases as the arterial pressure 
W<15 reduced. 
Phase I: Sudden appearance of a clear, but often faint, tapping 
sound growing louder. 
Phase II: The sOlU1ds are prolonged into a murmur. 
Plw.3C' III : The sOtmcls become clearer and increase in intensity. 
Pha.3c IY: The sounds quickly decrease in intensity and finally 
d isappear. 
It i.:: cf con:;iderable interest that the two papers on which con-
\ ";/1 I " 'l'ilI'Y !~: t" _ ho'];:; of estimating blood pressure are based, are inacces-
.~ i l, i, . ; " t lW >' t I'cadE' r;:; in the English-speaking world. W. Hall Lewis 
( I !H ! .1 :::: .l ici: · b···~ in the United States the only copy ofRiva-Rocci's 
paper i.'5 in ch~ _-lr::uy :\Iedical Library, and the only copy of Korotkoff's 
l'epurt is in t ~e Slavonic Division of the New York Public Library. 
With the .1."5i.mUlce of 2\1ir,s Gallagher, Librarian to St. Mary's Hospital 
::\Icdical Sr.'=.)C.l .. I have been unable to trace a single copy of either of 
t hese papf;~S iT' the libraries of Great Britain. 
L E.'Y.-':;' obcainerl translations of both papers, and I quote him as 
follows: 
1 ! ,, - - . - .: ·?i :::'.~: recorded the pW'p ose of his research on arterial pressure and 
t ht'r· =~ : ~':' :Lh rhe- simpler aspects of hydraulics involved. He gave a fairly 
\ ·01 ..•. :~ ...: ;-_,-. '.:.s rs"iew Ot the literature and described the three types of the von Basch 
'r .- :: _1 ::c.anome: ",,· u\'ai lable commercially at the time. He preferred the first, or !, . .: :-.: .: ::b~ . __ odcl co~pleted in IS8l, to the non-mercurial manometer produced in 
1 ~ ;,3 . gi',a -Rocci aciopted a modification of von Basch's instrument, which wu.s 
Si=:i.:" f : 0 that prop,- ~ed in 1881 by Rabinowitz, of which Riva-Rocci was not 
, \\ ' ,,-,:' . ?:\·.3. -R ·JCC l ·'; in;:; tnunent w.tg a " sphygmomanometer likewise based on 
t ll ':! p rinciple e5tablished by Vierordt and improved on by Maxey and von Basch in 
tUl·n. I n other word:;, it is an instrument affecting manometric measurement of 
t he forc.;, neces5al'Y ro impede the progreSilion of the undulation of the pulse. 
Sphy;momanometry is then applied to one of the large aortic branches, to the 
hUl'Or:: ra l. 5i..."l.ce the humeral is the direct continuation of the axillary (since the 
rei;ion con:ains no collateral large enough to be considered as a branch of the 
bi.fl~rCi\ : 'on ), the m easurement gives the total charge of a. point fairly close to the 
aOrTa . or, if you like, of the charge of pressure either in the aorta. itself (if the left 
hwnC)ral i3 concerned) or of the brachio-cepha.lic trunk (if the right humeral is 
concerned)." Ri\'a-Rocci considered tha.t his instrument was easy to a.pply, rapid 
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in action, precise, and innocuous. It was composed of two parts, one for exerting 
pressure, one for measuring the pressure exerted. The compressor apparatus was. 
represented by a tubular" muff " with walls soft, non-extensible, and imperme-
able to air. It consisted of a rubber tube 4 or 5 cm. in diameter, lined with a cloth 
sleeve to prevent undue dilation of the tube. One end of the tube was open, while 
the other was attached to a piece of metal made in two parts. The patient's arm 
was tested with this tube plus an insufflator. The intercalation of a manometer 
rovealed the pressure on the" muff" at all times, and hence the pressure exerted 
on the arm. 
Riva-Rocci stated: "The most reliable manometer is still the mercury 
manometer, but it is necessary to facilitate its reading by adopting a single 
branch, as in the manometers of :i\Iarey and of Fntn90is-Franck, -and the original 
model of von Basch. In order to render the apparatus easier to handle and 
transport, I, too, have adopted the metal manometer. So far, I have been able 
to obtain only the holosteric kind, since the aneroid kind is of more delicate 
constrnction." 
. . . Korotkoff's observations were given' at a meeting. of the Imperial 
:\Iilitary Academy in St. Petersburg, December, 1905 and reported in the 
bulletin of the Academy, "Izvestiya Voennomeditsinskaie Akademiia,"l page 
365. The original report occupies only a portion of one page in the bulletin, with 
the title: "On methods of studying blood pressw'e (from the Clinic of Prof. 
Feodoreff}." A translation in full reads: 
" On the basis of his observation, the speaker came to the conclusion that 
a perfectly constricted artery, under normal conditions, does not emit any 
sotmds. Taking this fact into consideration, the speaker proposes the sound 
method for measnring blood pressure on human beings. 'The sleeve of Riva-
Rocci is put on the middle third of the arm; the pressure in this sleeve rises 
rapidly until the circulation below this sleeve stops completely. At first there 
are no sour!ds whatsoever. P,-s the mercury in the manometer drops to a certain 
height, there appear the first short or faint tones, the appearance of which 
indicates that part of the pulse wave of the blood stream has passed under the 
sleeve. Consequently, the reading on the manometer when the first so lInd 
appears corresponds 'to the maximum blood pressure; with the further fall of 
the mercury h'l fna manometer, there are heard systolic pressure murmurs which 
become agai."l sOlmds (secondary). Finally all sounds disappear. The time of. 
the disappearance of the soundB indicates the free passage or flow of the blood 
stream; in other words, at the moment of the disappearance or fading out of 
the sounds, the 21inumum blood pressure in the artery has surpassed the pressure 
in the sleeve. Con.sequently, the readingofthe manometer at this time corresponds 
to the ::0':'1",1= blood pressure. Experiments conducted on animals gave 
positive results, The first sotmd tones appear (10-12 mm,) sooner than the 
pulEe which (1. ar. radialis) can be felt only after the passage ofthe major portion 
of the t·iood stream." 
There were now available three methods of determining the arterial 
pre~i'U:r'" from the inflation of a cuff on the upper arm; the suppression 
of ::he pulse as felt at the wrist, the Korotkoff sounds, and the pulsa-
tions of the air contained in the cuff. Many papers have been written 
0:; ti;:::sE- methods and their variations, their sources of error, accumcy, 
and convenience (see for example v. Recklinghausen's series in 1906 
and 1930). In the English-speaking world the auscultatory method 
has come to be almost the only method used. Von Recklinghausen 
pointed out that. the use of too small a cuff gave erroneously high 
readings, while the use of too large a cuff gave erroneously low readings. 
1 This should read Izvestiya Imperatorskoi Voenno-Meditsinskoi Akadernii. 
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SUMMARY 
This study was concerned with the measurement of blood pressure 
and the assessment of its patterns and variability in the young 
borderline hypertensive and normotensive male. The effects of 
prolonged p-adrenergic blockade were also studied in a placebo-
controlled trial of atenolol in 30 borderline hypertensives in 
whom echocardiographic and electrocardiographic parameters were 
examined for possible evidence of early hypertensive cardiac 
hypertrophy. 
Borderline hypertension was defined on the basis of blood pressure 
variation about the arbitrary limits of 140 mmHg systolic and/or 
90 mmHg diastolic during at least three separate office readings 
with random zero sphygmomanometry during a three month baseline 
period. The 15 normotensives in the study at no time exceeded 
these limits during a similar time period. 
Office and home blood pressure levels were significantly greater 
for borderline hypertensives compared to controls. Home blood 
pressure, however, was not significantly different from that 
recorded in the "stressful" hospital environment and this is 
contrary to the findings of previous studies. 
The significant difference in blood pressure between normotensives 
and hypertensives was apparent for the majority of 24 hours when 
continuous ambulatory, intra-arterial records were analysed. Both 
blood pressure categories demonstrated profound night-time falls 
17 
in blood pressure, with an early morning rise. Day-time 
continuous arterial pressure corresponded closely to indirect 
office and home readings. 
~-adrenergic blockade effectively lowered blood pressure in 
borderline individuals and although a non-significant fall in 
pressure was seen in office recordings in placebo-treated subjects 
this was not demonstrated in 24 hour recordings. The use of atenolol 
was accompanied by minimal side effects and was well tolerated. 
Baroreflex sensitivity was found to be reduced in borderline 
hypertensives, but after chronic p-adrenergic blockade there was 
a return of sensitivity towards the normotensive range. There 
was no correlation between the degree of blood pressure reduction 
and increase in sensitivity, so it seems unlikely that ~-blockers 
exert their antihypertensive action by a direct effect on the 
carotid baroreceptor mechanism. 
Despite reduced baroreflex sensitivity there was no evidence 
of increased blood pressure variability, measured by the standard 
deviations of the hourly means, from analysis of continuous 
ambulatory blood pressure records of borderline hypertensives. 
In a study of epidemiological data 27% of 913 young males aged 
between 16 and 35 years were found to have a blood pressure 
abnormality and 18% of these fell into the borderline category. 
Thirty per cent of young men of the remaining 9% with mild hyper-
tension satisfied criteria for electrocardiographic left ventricular 
hypertrophy. 
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Despite this observation there was no significant difference in 
electrocardiographic maximum precordial voltage between normo-
tensives and borderline hypertensives in the main area of this 
study. However, after identifying seven borderline hypertensives 
who fulfilled electrocardiographic left ventricular hypertrophy criteria 
it was found that their 24 hour intra-arterial blood pressure was 
significantly elevated throughout most of the day-time period when 
compared to non-hypertrophy individuals. These findings indicate 
a possible relationship between prolonged elevation of left 
ventricular after load and electrocardiographic appearances of 
ventricular hypertrophy. 
Blood pressure reduction had no effect on precordial voltage of 
the electrocardiogram, but at the end of six months there had been 
a significant increase in this measurement in the electrocardiograms 
of placebo-treated individuals. 
Echocardiographic measurement of posterior left ventricular wall 
thickness was found to be anatomically accurate, but no correlation 
was found between electrocardiographic maximum precordial voltage 
and septal and posterior wall thickness. At the same time no 
difference between the echo measurements was seen when normotensive 
and borderline hypertensive values were compared, but blood pressure 
lowering prevented the increase in septal and left ventricular wall 
thickness which was found at the end of six months in the placebo-
treated group. 
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The finding of a significant inverse relationship between 
baroreflex sensitivity and posterior wall and septal thickness 
suggested that early structural changes involving the vasculature 
and myocardium might already be operative and this observation is 
supported by the electrocardiographic and echocardiographic findings 
in this study of borderline hypertension. 
